{
    "years": [
      {
        "year": 1,
        "subjects": [
          {
            "name": "Anatomy",
            "topics": [
              {
                "title": "Skull",
                "description": "Study of the cranial and facial bones.",
                "notes": "### ğŸ¦´ Skull Overview\n\nThe human skull consists of **22 bones**, which are divided into:\n\n- **8 Cranial Bones**\n- **14 Facial Bones**\n\nIt forms the skeleton of the head and protects the brain while supporting facial structures.\n\n---\n\n### ğŸ§  Cranial Bones (8)\n\nThese bones enclose and protect the brain:\n\n1. **Frontal**\n2. **Parietal** (2)\n3. **Temporal** (2)\n4. **Occipital**\n5. **Sphenoid**\n6. **Ethmoid**\n\n> ğŸ§© The frontal bone forms the forehead and the roof of the orbits.\n\n---\n\n### ğŸ˜Š Facial Bones (14)\n\nThese shape the face and support sensory organs:\n\n- **Maxilla** (2)\n- **Zygomatic (cheekbones)** (2)\n- **Nasal** (2)\n- **Lacrimal** (2)\n- **Palatine** (2)\n- **Inferior nasal conchae** (2)\n- **Mandible** (1 â€” only movable skull bone)\n- **Vomer** (1)\n\n---\n\n### ğŸ•³ï¸ Important Foramina\n\nOpenings in the skull through which nerves and vessels pass:\n\n| Foramen           | Transmits                            |\n|------------------|--------------------------------------|\n| Foramen magnum   | Spinal cord, vertebral arteries      |\n| Optic canal      | Optic nerve (CN II)                  |\n| Jugular foramen  | CN IX, X, XI, jugular vein           |\n| Foramen ovale    | Mandibular branch of CN V (V3)       |\n\n---\n\n### ğŸ“Œ Clinical Relevance\n\n- **Fractures** of the skull can be life-threatening if cranial nerves or vessels are damaged.\n- The **pterion** is a thin region vulnerable to **epidural hematoma** if the middle meningeal artery is ruptured.\n\n---\n\n### ğŸ§  Key Takeaway\n\nThe skull is not a single bone but a complex structure of **22 bones** that together provide **protection**, **support**, and **access** for vital neurovascular structures."
                
                
          
              },
              {
                "title": "Vertebral Column",
                "description": "Anatomy and function of the human spine.",
                "notes": "### ğŸ¦´ Vertebral Column (Spine) Overview\n\nThe vertebral column is the **central support structure** of the body, made up of **33 vertebrae**:\n\n- 7 Cervical\n- 12 Thoracic\n- 5 Lumbar\n- 5 Sacral (fused)\n- 4 Coccygeal (fused)\n\n---\n\n### ğŸ§© Functions\n\n- **Supports** the skull and trunk\n- **Protects** the spinal cord\n- Allows **flexibility** and **movement**\n- Acts as an **attachment point** for ribs and muscles\n\n---\n\n### ğŸ§  Regions of the Spine\n\n| Region     | Vertebrae Count | Key Features                    |\n|------------|------------------|----------------------------------|\n| Cervical   | 7                | Small, bifid spinous processes   |\n| Thoracic   | 12               | Articulates with ribs            |\n| Lumbar     | 5                | Large bodies, weight-bearing     |\n| Sacral     | 5 (fused)        | Forms posterior pelvis (sacrum) |\n| Coccygeal  | 4 (fused)        | Vestigial tailbone (coccyx)      |\n\n---\n\n### ğŸ” Vertebra Structure\n\nEach typical vertebra has:\n\n- **Body**\n- **Vertebral foramen**\n- **Spinous process**\n- **Transverse processes**\n- **Articular facets**\n\n---\n\n### ğŸ©º Clinical Relevance\n\n- **Herniated Disc**: Displacement of intervertebral disc can compress spinal nerves (common in lumbar).\n- **Scoliosis**: Lateral curvature of the spine.\n- **Kyphosis**: Excessive posterior curvature (hunchback).\n- **Lordosis**: Exaggerated lumbar curve.\n\n---\n\n### ğŸ§  Key Takeaway\n\nThe spine is a flexible but strong column of **33 vertebrae** that provides **support, protection, and motion**, while housing the **spinal cord**."
              },

              {
                "title": "Anatomical Terminology",
                "description": "Fundamental positions, planes, and directional terms used in anatomy.",
                "notes": "### ğŸ§­ Anatomical Terminology & Orientation\n\nAnatomical terminology is essential for accurately describing **locations**, **positions**, and **relationships** of body structures.\n\n---\n\n### ğŸ“ Anatomical Position\n\nThe **standard reference position** for the human body:\n\n- Standing upright\n- Facing forward\n- Arms at the side\n- Palms facing forward\n- Feet slightly apart\n\n---\n\n### ğŸ§­ Anatomical Planes\n\n| Plane           | Description                                |\n|-----------------|--------------------------------------------|\n| **Sagittal**    | Divides the body into left & right         |\n| **Coronal**     | Divides the body into front & back         |\n| **Transverse**  | Divides the body into top & bottom         |\n| **Oblique**     | Any angled plane                           |\n\n---\n\n### ğŸ”€ Terms of Position\n\n| Term          | Meaning                           |\n|---------------|------------------------------------|\n| **Anterior**  | Front of the body                 |\n| **Posterior** | Back of the body                  |\n| **Superior**  | Above / toward head               |\n| **Inferior**  | Below / toward feet               |\n| **Medial**    | Toward midline                    |\n| **Lateral**   | Away from midline                 |\n| **Proximal**  | Closer to origin (limbs)          |\n| **Distal**    | Farther from origin (limbs)       |\n| **Superficial** | Closer to body surface         |\n| **Deep**      | Farther from surface              |\n\n---\n\n### ğŸ”„ Movements\n\n| Movement       | Description                         |\n|----------------|-------------------------------------|\n| **Flexion**    | Decreasing joint angle              |\n| **Extension**  | Increasing joint angle              |\n| **Abduction**  | Moving away from midline            |\n| **Adduction**  | Moving toward midline               |\n| **Rotation**   | Circular movement around an axis    |\n| **Supination** | Palm turns upward                   |\n| **Pronation**  | Palm turns downward                 |\n\n---\n\n### ğŸ§  Key Takeaway\n\nLearning standard anatomical terms helps ensure **clear communication** among healthcare professionals when describing parts of the body or performing procedures."

              },
              {
                "title": "Thoracic Wall & Ribs",
                "description": "Structure and function of the thoracic wall and rib cage.",
                "notes": "### ğŸ›¡ï¸ Thoracic Wall & Ribs\n\nThe thoracic wall consists of the rib cage, muscles, and fascia that protect the thoracic organs.\n\n---\n\n### ğŸ¦´ Rib Cage Structure\n\n- **12 pairs of ribs**:\n  - Ribs 1-7: True ribs (attach directly to the sternum)\n  - Ribs 8-10: False ribs (attach indirectly via costal cartilage)\n  - Ribs 11-12: Floating ribs (do not attach to the sternum)\n\n- **Sternum**: Manubrium, body, and xiphoid process.\n\n---\n\n### ğŸ‹ï¸â€â™‚ï¸ Muscles of the Thoracic Wall\n\n- **Intercostal muscles**: External, internal, and innermost intercostals aid in respiration.\n- **Diaphragm**: Primary muscle of respiration separating thoracic and abdominal cavities.\n\n---\n\n### ğŸ©º Clinical Relevance\n\n- **Rib Fractures**: Commonly occur due to trauma; may lead to pneumothorax.\n- **Thoracic Outlet Syndrome**: Compression of neurovascular structures between the clavicle and first rib.\n\n---\n\n### ğŸ§  Key Takeaway\n\nThe thoracic wall and rib cage provide structural support, protect vital organs, and play a crucial role in respiration."
              },
              {
                "title": "Lungs & Pleura",
                "description": "Anatomy and function of the lungs and pleural membranes.",
                "notes": "### ğŸŒ¬ï¸ Lungs & Pleura\n\nThe lungs are the primary organs of respiration, housed within the pleural cavities.\n\n---\n\n### ğŸ« Lung Anatomy\n\n- **Right Lung**: Three lobes (superior, middle, inferior) separated by horizontal and oblique fissures.\n- **Left Lung**: Two lobes (superior, inferior) separated by an oblique fissure; includes the cardiac notch.\n\n---\n\n### ğŸ©¹ Pleura\n\n- **Visceral Pleura**: Covers the lungs.\n- **Parietal Pleura**: Lines the thoracic cavity.\n- **Pleural Cavity**: Potential space between the two layers containing lubricating fluid.\n\n---\n\n### ğŸ©º Clinical Relevance\n\n- **Pneumothorax**: Air in the pleural cavity causing lung collapse.\n- **Pleural Effusion**: Excess fluid in the pleural cavity.\n\n---\n\n### ğŸ§  Key Takeaway\n\nUnderstanding the structure of the lungs and pleura is essential for diagnosing and treating respiratory conditions."
              },
              {
                "title": "Heart & Pericardium",
                "description": "Detailed anatomy of the heart and its surrounding pericardial sac.",
                "notes": "### â¤ï¸ Heart & Pericardium\n\nThe heart is a muscular organ responsible for pumping blood, enclosed within the pericardium.\n\n---\n\n### ğŸ«€ Heart Structure\n\n- **Chambers**: Right atrium, right ventricle, left atrium, left ventricle.\n- **Valves**: Tricuspid, pulmonary, mitral (bicuspid), aortic.\n\n---\n\n### ğŸ©¹ Pericardium\n\n- **Fibrous Pericardium**: Outer tough connective tissue layer.\n- **Serous Pericardium**: Inner double-layer with parietal and visceral layers; pericardial cavity contains lubricating fluid.\n\n---\n\n### ğŸ©º Clinical Relevance\n\n- **Pericarditis**: Inflammation of the pericardium.\n- **Cardiac Tamponade**: Accumulation of fluid in the pericardial cavity restricting heart function.\n\n---\n\n### ğŸ§  Key Takeaway\n\nA thorough understanding of the heart and pericardium is vital for recognizing and managing cardiovascular diseases."
              },
              {
                "title": "Abdominal Wall",
                "description": "Anatomical features of the abdominal wall and its clinical significance.",
                "notes": "### ğŸ‹ï¸ Abdominal Wall\n\nThe abdominal wall encloses the abdominal cavity and consists of multiple layers.\n\n---\n\n### ğŸ§± Layers (Superficial to Deep)\n\n1. Skin\n2. Superficial fascia (Camper's and Scarpa's layers)\n3. Muscles: External oblique, internal oblique, transversus abdominis\n4. Transversalis fascia\n5. Extraperitoneal fat\n6. Parietal peritoneum\n\n---\n\n### ğŸ‹ï¸â€â™‚ï¸ Muscles and Functions\n\n- **External Oblique**: Compresses abdomen, flexes and rotates trunk.\n- **Internal Oblique**: Same as external oblique.\n- **Transversus Abdominis**: Compresses abdominal contents.\n- **Rectus Abdominis**: Flexes vertebral column, compresses abdomen.\n\n---\n\n### ğŸ©º Clinical Relevance\n\n- **Hernias**: Protrusion of abdominal contents through the wall; common types include inguinal and umbilical hernias.\n\n---\n\n### ğŸ§  Key Takeaway\n\nThe abdominal wall's structure is crucial for protecting internal organs and maintaining intra-abdominal pressure."
              },
              {
                "title": "Gastrointestinal Tract",
                "description": "Comprehensive overview of the human gastrointestinal system.",
                "notes": "### ğŸ½ï¸ Gastrointestinal Tract\n\nThe gastrointestinal (GI) tract is a continuous tube extending from the mouth to the anus, facilitating digestion and absorption.\n\n---\n\n### ğŸ›¤ï¸ Major Components\n\n1. **Mouth**: Mechanical digestion begins; saliva initiates chemical digestion.\n2. **Esophagus**: Transports food to the stomach.\n3. **Stomach**: Secretes acid and enzymes; churns food into chyme.\n4. **Small Intestine**: Duodenum, jejunum, ileum; primary site for nutrient absorption.\n5. **Large Intestine**: Absorbs water; forms and stores feces.\n6. **Rectum & Anus**: Feces storage and elimination.\n\n---\n\n### ğŸ§ª Accessory Organs\n\n- **Liver**: Produces bile; processes nutrients and toxins.\n- **Gallbladder**: Stores and concentrates bile.\n- **Pancreas**: Produces digestive enzymes and bicarbonate.\n\n---\n\n### ğŸ©º Clinical Relevance\n\n- **GERD**: Acid reflux due to lower esophageal sphincter weakness.\n- **Peptic Ulcers**: Erosion of stomach/duodenal lining.\n- **Malabsorption Syndromes**: Celiac disease, lactose intolerance.\n\n---\n\n### ğŸ§  Key Takeaway\n\nThe GI tract is essential for digestion, absorption, and elimination â€” with critical support from the liver, gallbladder, and pancreas."
              },
              {
                "title": "Lower Limb",
                "description": "Detailed anatomy of the lower limb including bones, muscles, and neurovascular structures.",
                "notes": "### ğŸ¦µ Lower Limb Anatomy\n\nThe lower limb supports body weight and enables locomotion.\n\n---\n\n### ğŸ¦´ Bones\n\n- **Hip Bone** (ilium, ischium, pubis)\n- **Femur** (thigh)\n- **Patella** (kneecap)\n- **Tibia and Fibula** (leg)\n- **Tarsals, Metatarsals, Phalanges** (foot)\n\n---\n\n### ğŸ’ª Muscles\n\n- **Thigh**: Quadriceps (anterior), hamstrings (posterior), adductors (medial)\n- **Leg**: Anterior (dorsiflexors), posterior (plantarflexors), lateral (evertors)\n- **Gluteal Region**: Gluteus maximus, medius, minimus\n\n---\n\n### ğŸ©¸ Neurovascular Supply\n\n- **Arteries**: External iliac â†’ Femoral â†’ Popliteal â†’ Tibial\n- **Nerves**: Sciatic (largest), femoral, obturator, tibial, common peroneal\n\n---\n\n### ğŸ©º Clinical Relevance\n\n- **Femoral Neck Fracture**: Common in elderly; leads to avascular necrosis\n- **Sciatica**: Pain due to sciatic nerve compression\n\n---\n\n### ğŸ§  Key Takeaway\n\nThe lower limb provides structural stability and powerful motion for walking, running, and standing."
              },
              {
                "title": "Cranial Nerves",
                "description": "An overview of the 12 cranial nerves, their functions, and clinical importance.",
                "notes": "### ğŸ§  Cranial Nerves\n\nThere are **12 pairs of cranial nerves**, emerging directly from the brain.\n\n---\n\n### ğŸ§¬ Overview\n\n| CN | Name               | Function                    |\n|----|--------------------|-----------------------------|\n| I  | Olfactory          | Smell                       |\n| II | Optic              | Vision                      |\n| III| Oculomotor         | Eye movement, pupil constriction |\n| IV | Trochlear          | Eye movement (superior oblique) |\n| V  | Trigeminal         | Facial sensation, mastication |\n| VI | Abducens           | Eye movement (lateral rectus) |\n| VII| Facial             | Facial expression, taste (anterior 2/3 tongue) |\n| VIII| Vestibulocochlear | Hearing and balance         |\n| IX | Glossopharyngeal   | Taste (posterior 1/3), swallowing |\n| X  | Vagus              | Autonomic control, swallowing, speech |\n| XI | Accessory          | Shoulder and neck movement |\n| XII| Hypoglossal        | Tongue movement             |\n\n---\n\n### ğŸ©º Clinical Relevance\n\n- **Bellâ€™s Palsy**: CN VII paralysis â†’ facial muscle weakness\n- **Trigeminal Neuralgia**: Intense facial pain along CN V\n\n---\n\n### ğŸ§  Key Takeaway\n\nCranial nerves are vital for sensory, motor, and autonomic functions â€” each has a distinct clinical test."
              }
               ,
           {
              "title": "Brain & Meninges",
              "description": "Anatomical divisions of the brain and protective coverings.",
              "notes": "### ğŸ§  Brain & Meninges\n\nThe brain is the control center of the body, enclosed by **meninges** that provide protection.\n\n---\n\n### ğŸ§¬ Brain Divisions\n\n- **Cerebrum**: Largest part, responsible for cognition, emotion, motor, and sensory processing\n- **Cerebellum**: Coordination and balance\n- **Brainstem**: Midbrain, pons, medulla â€” autonomic and relay functions\n\n---\n\n### ğŸ›¡ï¸ Meninges (from outer to inner)\n\n1. **Dura mater** â€” Tough outer layer\n2. **Arachnoid mater** â€” Web-like, CSF circulation\n3. **Pia mater** â€” Thin inner membrane directly on brain\n\n---\n\n### ğŸ§ª CSF Circulation\n\n- Produced in **choroid plexus** â†’ ventricles â†’ subarachnoid space â†’ reabsorbed into dural sinuses\n\n---\n\n### ğŸ©º Clinical Relevance\n\n- **Meningitis**: Inflammation of meninges\n- **Hydrocephalus**: CSF accumulation â†’ increased intracranial pressure\n\n---\n\n### ğŸ§  Key Takeaway\n\nUnderstanding the layers and structure of the brain and meninges is critical for managing neurological conditions."
            },

             {
               "title": "Eye & Orbit",
               "description": "Structures of the eye and the bony orbit housing them.",
               "notes": "### ğŸ‘ï¸ Eye & Orbit\n\nThe **orbit** contains the eyeball, muscles, nerves, and vessels.\n\n---\n\n### ğŸ¦´ Orbital Anatomy\n\n- Formed by 7 bones: frontal, sphenoid, zygomatic, maxilla, palatine, ethmoid, lacrimal\n\n---\n\n### ğŸ‘ï¸ Eyeball Layers\n\n1. **Fibrous**: Cornea, sclera\n2. **Vascular**: Choroid, ciliary body, iris\n3. **Retina**: Photoreceptors (rods/cones)\n\n---\n\n### ğŸ§¬ Muscles of the Eye\n\n- **6 Extraocular muscles**: Superior, inferior, medial, lateral rectus; superior/inferior oblique\n\n---\n\n### ğŸ©º Clinical Relevance\n\n- **Strabismus**: Misalignment of eyes\n- **Glaucoma**: Increased intraocular pressure damaging optic nerve\n\n---\n\n### ğŸ§  Key Takeaway\n\nThe eye and its orbit are complex sensory and motor structures essential for vision and gaze control."
              }                       
            ]
            
            
          },

          
          {
            "name": "Biochemistry",
            "topics": [
              {
                "title": "Glycolysis",
                "description": "Main metabolic pathway for glucose breakdown.",
                "notes": "### âš¡ Glycolysis: Fast Glucose Breakdown\n\n**Glycolysis** is a key metabolic pathway that converts **glucose (6C)** into **2 pyruvate (3C)**, generating energy.\n\n---\n\n### ğŸ“ Location\n- **Cytoplasm** of all cells (aerobic & anaerobic)\n\n---\n\n### ğŸ”‘ Key Points\n- Net yield: **2 ATP**, **2 NADH** (per glucose)\n- No oxygen required (anaerobic-capable)\n- First step of cellular respiration\n\n---\n\n### ğŸ§¬ Rate-Limiting Enzyme\n- **Phosphofructokinase-1 (PFK-1)**\n  - Activated by AMP, inhibited by ATP & citrate\n\n---\n\n### ğŸ§ª Important Steps\n1. **Glucose â†’ G6P** (Hexokinase)\n2. **F6P â†’ F1,6BP** (PFK-1) â† ğŸ”¥ commitment step\n3. **PEP â†’ Pyruvate** (Pyruvate kinase)\n\n---\n\n### ğŸ©º Clinical Relevance\n- **Pyruvate kinase deficiency** â†’ hemolytic anemia\n- **Warburg effect** in cancer cells = high glycolysis even with oxygen\n\n---\n\n### ğŸ§  Key Takeaway\nGlycolysis provides **quick ATP**, operates without oxygen, and feeds into multiple critical pathways (TCA, lactate, acetyl-CoA)."
              },
              {
                "title": "TCA Cycle",
                "description": "Central metabolic cycle that oxidizes acetyl-CoA into COâ‚‚ and energy.",
                "notes": "### ğŸ” TCA Cycle (Krebs Cycle)\n\nThe **TCA cycle** oxidizes **acetyl-CoA** into **COâ‚‚**, producing high-energy molecules.\n\n---\n\n### ğŸ“ Location\n- **Mitochondrial matrix**\n\n---\n\n### ğŸ”‘ Key Products (Per Acetyl-CoA)\n- **3 NADH**\n- **1 FADHâ‚‚**\n- **1 GTP (ATP)**\n- **2 COâ‚‚**\n\n---\n\n### â›½ Entry Point\n- Acetyl-CoA + Oxaloacetate â†’ Citrate\n\n### ğŸ§¬ Rate-Limiting Enzyme\n- **Isocitrate dehydrogenase**\n\n---\n\n### ğŸ©º Clinical Relevance\n- Inhibited by ATP, NADH, citrate\n- **Anaplerotic reactions** replenish cycle intermediates\n\n---\n\n### ğŸ§  Key Takeaway\nThe TCA cycle is a **hub of metabolism**, feeding into the ETC and providing substrates for biosynthesis."
              },
              {
                "title": "Electron Transport Chain",
                "description": "Final step of aerobic respiration producing ATP via oxidative phosphorylation.",
                "notes": "### âš™ï¸ Electron Transport Chain (ETC)\n\nThe **ETC** uses electrons from NADH/FADHâ‚‚ to generate **ATP** via proton pumping.\n\n---\n\n### ğŸ“ Location\n- **Inner mitochondrial membrane**\n\n---\n\n### ğŸ§¬ Key Complexes\n- **Complex I**: NADH â†’ CoQ\n- **Complex II**: FADHâ‚‚ â†’ CoQ\n- **Complex III**: CoQ â†’ Cyt c\n- **Complex IV**: Cyt c â†’ Oâ‚‚ â†’ Hâ‚‚O\n- **ATP Synthase** (Complex V): Makes ATP using Hâº gradient\n\n---\n\n### ğŸ©º Clinical Relevance\n- Blocked by cyanide (Complex IV), rotenone (I), oligomycin (V)\n- ETC defects = mitochondrial disease\n\n---\n\n### ğŸ§  Key Takeaway\nETC is the **main source of ATP**, coupling electron transfer to proton gradient & ATP production."
              },
              {
                "title": "Enzyme Kinetics",
                "description": "Study of enzyme reaction rates and their regulation.",
                "notes": "### â±ï¸ Enzyme Kinetics\n\nDescribes how **substrate concentration** affects enzyme activity.\n\n---\n\n### ğŸ§® Michaelis-Menten Equation\nv = (Vmax Ã— [S]) / (Km + [S])\n\n- **Km**: [S] at Â½ Vmax\n- **Vmax**: Max rate at enzyme saturation\n\n---\n\n### ğŸ“‰ Lineweaver-Burk Plot\n- Double-reciprocal plot of Michaelis-Menten equation\n- Useful to distinguish inhibition types\n\n---\n\n### ğŸ”’ Inhibition Types\n- **Competitive**: â†‘Km, same Vmax\n- **Non-competitive**: â†“Vmax, same Km\n\n---\n\n### ğŸ§  Key Takeaway\nEnzyme kinetics is critical for **drug development** and understanding **metabolic control**."
              },
              {
                "title": "Protein Structure",
                "description": "Levels of organization of protein structure.",
                "notes": "### ğŸ§¬ Protein Structure\n\nProteins fold into specific shapes essential for their function.\n\n---\n\n### ğŸ§± 4 Structural Levels\n1. **Primary**: Amino acid sequence (peptide bonds)\n2. **Secondary**: Î±-helices, Î²-sheets (H-bonds)\n3. **Tertiary**: 3D folding (disulfide, ionic, hydrophobic)\n4. **Quaternary**: Multiple subunits (e.g. Hb = 4 chains)\n\n---\n\n### ğŸ§  Key Takeaway\nStructure determines function â†’ misfolding = disease (e.g. Alzheimerâ€™s, prions)."
              },
              {
                "title": "Amino Acid Metabolism",
                "description": "Pathways of amino acid utilization, transamination, and deamination.",
                "notes": "### ğŸ§ª Amino Acid Metabolism\n\nAmino acids are used for **protein synthesis**, energy, or converted into glucose/ketones.\n\n---\n\n### ğŸ”„ Key Processes\n- **Transamination**: Transfer amino group â†’ Î±-ketoglutarate\n- **Deamination**: Ammonia removed â†’ Urea\n- **Glucogenic**: â†’ Glucose\n- **Ketogenic**: â†’ Ketone bodies\n\n---\n\n### ğŸ©º Clinical Relevance\n- **PKU**: Defective phenylalanine metabolism\n- **Maple Syrup Urine Disease**: Branched-chain AA defect\n\n---\n\n### ğŸ§  Key Takeaway\nAmino acid metabolism links **protein breakdown** to **energy metabolism** and **nitrogen disposal**."
              },
              {
                "title": "Lipid Metabolism",
                "description": "Breakdown and synthesis of fatty acids and cholesterol.",
                "notes": "### ğŸ§ˆ Lipid Metabolism\n\nLipids provide long-term energy and membrane structure.\n\n---\n\n### ğŸ”¥ Key Pathways\n- **Î²-oxidation**: FA â†’ Acetyl-CoA â†’ TCA (mitochondria)\n- **Lipogenesis**: Acetyl-CoA â†’ FA (cytoplasm)\n- **Cholesterol synthesis**: HMG-CoA â†’ Mevalonate â†’ Cholesterol\n\n---\n\n### ğŸ©º Clinical Relevance\n- **Fatty liver**, **hyperlipidemia**, **statins** inhibit HMG-CoA reductase\n\n---\n\n### ğŸ§  Key Takeaway\nLipid metabolism balances **energy**, **storage**, and **hormone synthesis**."
              },
              {
                "title": "Nucleotide Metabolism",
                "description": "Synthesis and breakdown of purines and pyrimidines.",
                "notes": "### ğŸ§¬ Nucleotide Metabolism\n\nNucleotides are essential for **DNA/RNA synthesis** and **energy transfer (ATP)**.\n\n---\n\n### ğŸ§ª Synthesis\n- **Purines**: Built on ribose-P â†’ AMP/GMP\n- **Pyrimidines**: Ring built first â†’ added to ribose (UMP â†’ CTP/TMP)\n\n---\n\n### ğŸ” Salvage Pathway\n- Recycles free bases â†’ efficient reuse (important in brain)\n\n---\n\n### ğŸ©º Clinical Relevance\n- **Lesch-Nyhan Syndrome**: HGPRT deficiency â†’ â†‘uric acid\n- **Gout**: Uric acid crystal deposition\n\n---\n\n### ğŸ§  Key Takeaway\nBalanced nucleotide metabolism is vital for **genetic stability** and **cell division**."
              }
            ]
          },
          


          {
            "name": "Histology",
            "topics": [
              {
                "title": "Introduction to Histology",
                "description": "Overview of histology as the study of tissues, including microscope basics and tissue classification.",
                "notes": "### ğŸ§« Introduction to Histology\n\nHistology is the **microscopic study of tissues** and how they organize to form organs.\n\n---\n\n### ğŸ”¬ Microscopy Basics\n- **Light Microscopy**: Most common for staining\n- **Electron Microscopy (TEM/SEM)**: For ultrastructure\n\n---\n\n### ğŸ“Œ Tissue Processing Steps\n1. Fixation (formalin)\n2. Embedding (paraffin)\n3. Sectioning (~5 Âµm)\n4. Staining (H&E most common)\n\n---\n\n### ğŸ§  Major Tissue Types\n1. **Epithelial**\n2. **Connective**\n3. **Muscle**\n4. **Nervous**"
              },
              {
                "title": "Epithelium",
                "description": "Classification and function of epithelial tissues.",
                "notes": "### ğŸ§± Epithelium\n\nEpithelial tissues **line surfaces, protect organs**, and form **glands**.\n\n---\n\n### ğŸ“Œ Classification\n- **By Layers**:\n  - Simple (1 layer)\n  - Stratified (>1 layer)\n  - Pseudostratified (appears layered, isn't)\n- **By Shape**:\n  - Squamous (flat)\n  - Cuboidal (cube)\n  - Columnar (tall)\n\n---\n\n### ğŸ” Key Locations\n- Simple squamous: Alveoli, endothelium\n- Simple cuboidal: Kidney tubules\n- Pseudostratified: Respiratory tract\n- Stratified squamous: Skin, esophagus\n\n---\n\n### ğŸ§  Key Takeaway\nEpithelia are **polarized**, **avascular**, and rest on a **basement membrane**."
              },
              {
                "title": "Connective Tissue",
                "description": "Overview of connective tissue types, components, and functions.",
                "notes": "### ğŸ§µ Connective Tissue\n\nSupports, binds, and protects tissues. Most **abundant and diverse** tissue type.\n\n---\n\n### ğŸ”¬ Components\n- **Cells**: Fibroblasts, adipocytes, macrophages\n- **Fibers**: Collagen (strength), Elastic (stretch), Reticular (framework)\n- **Ground Substance**: Fills space, supports exchange\n\n---\n\n### ğŸ“Œ Types\n- **Loose (Areolar)**: Under epithelium\n- **Dense Regular**: Tendons, ligaments\n- **Dense Irregular**: Dermis, capsules\n- **Specialized**: Cartilage, Bone, Blood\n\n---\n\n### ğŸ§  Key Takeaway\nCT connects and supports other tissues â€” **structure and repair** are its core jobs."
              },
              {
                "title": "Muscle Tissue",
                "description": "Structure and function of skeletal, cardiac, and smooth muscle tissues.",
                "notes": "### ğŸ’ª Muscle Tissue\n\nMuscle tissue generates **movement**, **posture**, and **heat**.\n\n---\n\n### ğŸ“Œ Types\n1. **Skeletal**: Striated, multinucleated, voluntary\n2. **Cardiac**: Striated, single nucleus, intercalated discs, involuntary\n3. **Smooth**: Non-striated, fusiform cells, involuntary\n\n---\n\n### ğŸ” Locations\n- Skeletal: Attached to bone\n- Cardiac: Heart wall\n- Smooth: GI tract, bladder, vessels\n\n---\n\n### ğŸ§  Key Takeaway\nMuscle types differ by **appearance**, **location**, and **control mechanism**."
              },
              {
                "title": "Nervous Tissue",
                "description": "Components and functions of nervous tissue.",
                "notes": "### ğŸ§  Nervous Tissue\n\nDesigned for **rapid communication** and control.\n\n---\n\n### ğŸ“Œ Components\n- **Neurons**: Conduct signals (dendrites â†’ axon)\n- **Neuroglia (Glia)**: Support cells\n  - CNS: Astrocytes, oligodendrocytes, microglia, ependymal\n  - PNS: Schwann cells, satellite cells\n\n---\n\n### ğŸ”Œ Synapse Basics\n- Electrical signal â†’ Chemical (NT) â†’ Next neuron\n- Common NTs: ACh, dopamine, serotonin, GABA\n\n---\n\n### ğŸ§  Key Takeaway\nNervous tissue powers **sensation, reflexes, thinking**, and **motor control**."
              }
            ]
          },
          
        
          {
            "name": "Physiology",
            "topics": [
              {
                "title": "Cell Physiology",
                "description": "Fundamental concepts of cell function and signaling.",
                "notes": "### ğŸ”¬ Cell Physiology\n\nCell physiology focuses on **homeostasis, signaling**, and **transport** mechanisms that allow cells to survive and function.\n\n---\n\n### ğŸ§¬ Key Concepts\n- **Membrane Potential**: Maintained by Naâº/Kâº ATPase\n- **Diffusion**: Passive, down concentration gradient\n- **Facilitated Diffusion**: Requires transporter\n- **Active Transport**: Uses ATP (e.g. Naâº/Kâº pump)\n- **Endo-/Exocytosis**: Vesicle-mediated transport\n\n---\n\n### ğŸ“¡ Cell Signaling\n- **Receptor Types**: Ion channel, GPCR, enzyme-linked\n- **Second Messengers**: cAMP, IPâ‚ƒ, DAG, CaÂ²âº\n\n---\n\n### ğŸ§  Key Takeaway\nCell physiology explains how **molecules move**, **signals transmit**, and **homeostasis** is maintained at the cellular level."
              },
              {
                "title": "Neurophysiology",
                "description": "Functioning of the nervous system and neural pathways.",
                "notes": "### ğŸ§  Neurophysiology\n\nStudies how the nervous system **transmits, integrates**, and **responds** to information.\n\n---\n\n### ğŸ”Œ Action Potential\n- Resting potential: ~â€“70 mV\n- Depolarization: Naâº influx\n- Repolarization: Kâº efflux\n- Refractory periods: Absolute vs relative\n\n---\n\n### ğŸ” Synaptic Transmission\n- **Chemical synapses**: Use neurotransmitters\n- **Excitatory vs Inhibitory**: EPSP (Naâº) / IPSP (Clâ»)\n- Common NTs: ACh, dopamine, GABA, glutamate\n\n---\n\n### ğŸ§  Key Takeaway\nNeurophysiology bridges **electrical signals and brain function**, essential for understanding reflexes, movement, and sensation."
              },
              {
                "title": "Cardiovascular Physiology",
                "description": "Mechanics of heart function and blood circulation.",
                "notes": "### â¤ï¸ Cardiovascular Physiology\n\nDescribes how the heart and blood vessels maintain **blood flow** and **oxygen delivery**.\n\n---\n\n### ğŸ” Cardiac Cycle\n- Phases: Diastole (filling), Systole (ejection)\n- Heart sounds: S1 (AV close), S2 (semilunar close)\n\n---\n\n### ğŸ’“ Electrical Conduction\n- SA â†’ AV â†’ Bundle of His â†’ Purkinje\n- ECG: P wave, QRS, T wave\n\n---\n\n### ğŸ§ª Hemodynamics\n- **CO = HR Ã— SV**\n- BP regulated by baroreceptors, RAAS, sympathetic tone\n\n---\n\n### ğŸ§  Key Takeaway\nCardiovascular physiology links **pressure, flow, resistance** â€” critical for diagnosing hypertension, arrhythmias, and shock."
              },
              {
                "title": "Respiratory Physiology",
                "description": "Processes involved in gas exchange and breathing.",
                "notes": "### ğŸ« Respiratory Physiology\n\nCovers **ventilation**, **gas exchange**, and **oxygen transport**.\n\n---\n\n### ğŸŒ¬ï¸ Mechanics of Breathing\n- Inspiration: Diaphragm contracts, lungs expand\n- Expiration: Passive (normal) or active (forced)\n\n---\n\n### ğŸ§¬ Gas Exchange\n- Occurs in **alveoli**\n- Oâ‚‚ diffuses into blood, COâ‚‚ diffuses out\n- Driven by partial pressure gradients (PaOâ‚‚, PaCOâ‚‚)\n\n---\n\n### ğŸ©¸ Oxygen Transport\n- 98% bound to Hb\n- **Oâ‚‚-Hb dissociation curve**: Shift right = â†“affinity\n\n---\n\n### ğŸ§  Key Takeaway\nUnderstanding ventilation and perfusion is vital for managing **asthma**, **COPD**, and **respiratory failure**."
              },
              {
                "title": "Renal Physiology",
                "description": "Kidney function and urine formation.",
                "notes": "### ğŸ©¸ Renal Physiology\n\nExplains how the kidneys **filter blood**, **maintain homeostasis**, and **form urine**.\n\n---\n\n### ğŸŒ€ Nephron Function\n1. **Filtration** at glomerulus\n2. **Reabsorption** (PCT â†’ Loop â†’ DCT)\n3. **Secretion** of Hâº, Kâº, drugs\n4. **Excretion** = Filtration â€“ Reabsorption + Secretion\n\n---\n\n### âš–ï¸ Regulation\n- ADH: â†‘ water reabsorption (collecting duct)\n- Aldosterone: â†‘ Naâº reabsorption, Kâº secretion\n- Renin-Angiotensin-Aldosterone System (RAAS): BP control\n\n---\n\n### ğŸ§  Key Takeaway\nRenal physiology underpins **fluid/electrolyte balance**, **acid-base homeostasis**, and **BP regulation**."
              }
            ]
          },
          
          {
            "name": "Genetics",
            "topics": [
              {
                "title": "DNA Structure and Replication",
                "description": "Molecular composition of DNA and the replication process.",
                "notes": "### ğŸ§¬ DNA Structure and Replication\n\n**DNA** is a double-stranded helix composed of nucleotides: **adenine (A)**, **thymine (T)**, **guanine (G)**, and **cytosine (C)**.\n\n---\n\n### ğŸ§± Structure\n- Sugar-phosphate backbone\n- A-T and G-C base pairing (H-bonds)\n- Antiparallel strands (5' â†’ 3', 3' â†’ 5')\n\n---\n\n### ğŸ” Replication Process\n- Semi-conservative (one new + one old strand)\n- **DNA helicase**: Unwinds helix\n- **DNA polymerase**: Adds nucleotides (needs primer)\n- **Ligase**: Joins Okazaki fragments on lagging strand\n\n---\n\n### ğŸ§  Key Takeaway\nDNA's structure enables accurate replication, essential for inheritance and cell division."
              },
              {
                "title": "Mendelian Inheritance",
                "description": "Basic laws of inheritance and genetic patterns.",
                "notes": "### ğŸ§ª Mendelian Inheritance\n\nFounded by **Gregor Mendel**, this describes how traits are inherited via **alleles**.\n\n---\n\n### ğŸ“œ Mendelâ€™s Laws\n1. **Law of Segregation**: Each gamete receives one allele\n2. **Law of Independent Assortment**: Genes for different traits sort independently\n\n---\n\n### ğŸ”¢ Inheritance Patterns\n- **Autosomal Dominant**: One copy enough (e.g. Marfan)\n- **Autosomal Recessive**: Both copies (e.g. CF)\n- **X-Linked Recessive**: More common in males (e.g. hemophilia)\n\n---\n\n### ğŸ§  Key Takeaway\nMendelian rules explain **predictable trait patterns**, key to diagnosing genetic diseases."
              },
              {
                "title": "Mutations and Genetic Disorders",
                "description": "Types of mutations and common inherited diseases.",
                "notes": "### ğŸ§¬ Mutations and Genetic Disorders\n\nA **mutation** is a permanent change in the DNA sequence.\n\n---\n\n### ğŸ”§ Mutation Types\n- **Point Mutation**: Single base change (missense, nonsense, silent)\n- **Frameshift**: Insertion/deletion â†’ reading frame altered\n- **Chromosomal**: Large deletions, duplications, inversions\n\n---\n\n### âš ï¸ Genetic Disorders\n- **Cystic Fibrosis**: Î”F508 deletion\n- **Sickle Cell Anemia**: Missense mutation in Î²-globin\n- **Down Syndrome**: Trisomy 21 (non-Mendelian)\n\n---\n\n### ğŸ§  Key Takeaway\nMutations can disrupt gene function, leading to **inherited or developmental disorders**."
              },
              {
                "title": "Population Genetics",
                "description": "Genetic variation and evolution in populations.",
                "notes": "### ğŸŒ Population Genetics\n\nStudies how allele frequencies change in populations over time.\n\n---\n\n### ğŸ§® Hardy-Weinberg Principle\n- Genotype frequencies: pÂ² + 2pq + qÂ² = 1\n- Assumes: No mutation, random mating, no migration, large pop, no selection\n\n---\n\n### ğŸ“‰ Factors Affecting Allele Frequencies\n- **Mutation**\n- **Gene flow (migration)**\n- **Genetic drift (random)**\n- **Selection (natural/sexual)**\n- **Non-random mating**\n\n---\n\n### ğŸ§  Key Takeaway\nPopulation genetics links **evolution, diversity**, and **disease susceptibility**."
              }
            ]
          },
          
          {
            "name": "Embryology",
            "topics": [
              {
                "title": "Fertilization and Early Development",
                "description": "From zygote to blastocyst and implantation.",
                "notes": "### ğŸ§¬ Fertilization and Early Development\n\nDevelopment begins when a **sperm fertilizes an ovum**, forming a **zygote** (diploid cell).\n\n---\n\n### ğŸ”„ Stages\n1. **Cleavage**: Rapid mitotic divisions â†’ morula (16â€“32 cells)\n2. **Blastocyst**: Fluid-filled cavity forms (blastocoel); inner cell mass becomes embryo\n3. **Implantation**: Blastocyst embeds into endometrium (around day 6â€“7)\n\n---\n\n### ğŸ§  Key Takeaway\nEarly development forms the groundwork for **germ layer differentiation** and **placental development**."
              },
              {
                "title": "Gastrulation and Germ Layers",
                "description": "Formation of the three primary germ layers.",
                "notes": "### ğŸ” Gastrulation and Germ Layers\n\nGastrulation creates a **trilaminar embryo** from a bilaminar disc.\n\n---\n\n### ğŸ“Œ Process\n- Starts with formation of **primitive streak**\n- **Epiblast cells** migrate inward\n\n---\n\n### ğŸ¯ Germ Layers\n- **Ectoderm**: Skin, CNS, eyes\n- **Mesoderm**: Muscles, bones, heart, kidneys\n- **Endoderm**: Gut lining, lungs, liver, pancreas\n\n---\n\n### ğŸ§  Key Takeaway\nEach germ layer gives rise to specific tissues â†’ **mastering this unlocks full organogenesis.**"
              },
              {
                "title": "Neurulation",
                "description": "Formation of the neural tube from ectoderm.",
                "notes": "### ğŸ§  Neurulation\n\nNeurulation converts the ectoderm into the **neural tube**, the precursor of the **central nervous system**.\n\n---\n\n### ğŸ§¬ Steps\n1. **Notochord** induces ectoderm â†’ neural plate\n2. Neural plate â†’ folds â†’ fuse to form neural tube\n3. **Neural crest cells**: Migrate to form PNS, adrenal medulla, melanocytes\n\n---\n\n### âš ï¸ Clinical Relevance\n- Failure to close â†’ **neural tube defects** (anencephaly, spina bifida)\n- Folic acid â†“ risk\n\n---\n\n### ğŸ§  Key Takeaway\nNeurulation is essential for CNS development â€” **early folate support is critical.**"
              },
              {
                "title": "Fetal Membranes and Placenta",
                "description": "Development and function of amnion, chorion, and placenta.",
                "notes": "### ğŸ›¡ï¸ Fetal Membranes and Placenta\n\nFetal membranes and placenta support and protect the embryo throughout gestation.\n\n---\n\n### ğŸ§ƒ Membranes\n- **Amnion**: Fluid-filled sac; cushions embryo\n- **Chorion**: Forms part of placenta\n- **Yolk Sac**: Early blood/nutrient source\n- **Allantois**: Contributes to umbilical cord\n\n---\n\n### ğŸ§  Placenta\n- Formed from **trophoblast + maternal decidua**\n- Site of **gas, nutrient, waste exchange**\n- Produces hormones: hCG, progesterone, estrogens\n\n---\n\n### ğŸ§  Key Takeaway\nThe placenta is the **lifeline** of fetal life and a **hormonal factory.**"
              },
              {
                "title": "Developmental Defects",
                "description": "Major congenital anomalies and their origins.",
                "notes": "### âš ï¸ Developmental Defects\n\nBirth defects arise due to **genetic errors**, **teratogens**, or **timing issues** in development.\n\n---\n\n### ğŸ§¬ Types\n- **Malformation**: Intrinsic (e.g. neural tube defect)\n- **Deformation**: External mechanical force (e.g. clubfoot)\n- **Disruption**: External breakdown (e.g. amniotic band)\n\n---\n\n### â±ï¸ Critical Periods\n- Weeks 3â€“8: Organogenesis = highest risk window\n\n---\n\n### ğŸ§ª Examples\n- Teratogens: Alcohol â†’ FAS, Retinoic acid, Thalidomide\n- Chromosomal: Trisomy 21, Turner, Klinefelter\n\n---\n\n### ğŸ§  Key Takeaway\nPreventing defects starts with **maternal health**, **folate**, and **timing awareness**."
              }
            ]
          }
          
          
        ]},
      {
        "year": 2,
        "subjects": [
          {
            "name": "Pathology",
            "topics": [
              {
                "title": "Cell Injury and Death",
                "description": "Mechanisms of reversible and irreversible cell injury.",
                "notes": "### ğŸ§¬ Cell Injury and Death\n\nPathology begins with **cell stress** â†’ **adaptation or injury**.\n\n---\n\n### ğŸ” Reversible Injury\n- **Cell swelling**: Naâº/Kâº pump failure\n- **Fatty change**: Liver, heart\n- Recovery possible if stress removed\n\n---\n\n### âŒ Irreversible Injury\n- Membrane damage\n- CaÂ²âº influx â†’ enzyme activation\n- Nuclear changes: Pyknosis â†’ karyorrhexis â†’ karyolysis\n\n---\n\n### â˜ ï¸ Cell Death Types\n- **Necrosis**: Inflammatory, enzyme-mediated (coagulative, liquefactive, caseous)\n- **Apoptosis**: Programmed, non-inflammatory (DNA laddering, caspases)\n\n---\n\n### ğŸ§  Key Takeaway\n**Timing and severity** decide if cell injury is **reversible** or leads to **necrosis/apoptosis**."
              },
              {
                "title": "Inflammation",
                "description": "Acute and chronic inflammation processes.",
                "notes": "### ğŸ”¥ Inflammation\n\nResponse to injury â†’ eliminate cause and repair tissue.\n\n---\n\n### âš¡ Acute Inflammation\n- Time: Minutes to hours\n- Cells: Neutrophils\n- Mediators: Histamine, prostaglandins, bradykinin\n- Signs: Rubor, calor, tumor, dolor, functio laesa\n\n---\n\n### ğŸ•°ï¸ Chronic Inflammation\n- Time: Days to years\n- Cells: Macrophages, lymphocytes, plasma cells\n- Leads to: Fibrosis, granuloma (e.g. TB)\n\n---\n\n### ğŸ§  Key Takeaway\nAcute = **rapid**, neutrophilic; chronic = **persistent**, mononuclear â€” both critical in disease progression."
              },
              {
                "title": "Neoplasia",
                "description": "Tumor biology, classification, and cancer hallmarks.",
                "notes": "### ğŸ¦  Neoplasia\n\nUncontrolled, irreversible **abnormal growth** of cells.\n\n---\n\n### ğŸ“Œ Terms\n- **Hyperplasia**: â†‘ cell number (reversible)\n- **Dysplasia**: Disordered growth (pre-cancer)\n- **Neoplasm**: True tumor (benign/malignant)\n\n---\n\n### ğŸ§¬ Hallmarks of Cancer (Hanahan & Weinberg)\n1. Evade apoptosis\n2. Self-sufficiency in growth signals\n3. Insensitivity to anti-growth\n4. Sustained angiogenesis\n5. Limitless replication\n6. Tissue invasion/metastasis\n\n---\n\n### ğŸ§  Key Takeaway\nCancer = genetic damage + unchecked division + **metastatic potential**."
              },
              {
                "title": "Hemodynamic Disorders",
                "description": "Edema, thrombosis, embolism, shock.",
                "notes": "### ğŸ’‰ Hemodynamic Disorders\n\nDisruptions in **blood flow or vascular integrity**.\n\n---\n\n### ğŸ’§ Edema\n- â†‘ Hydrostatic pressure (CHF)\n- â†“ Oncotic pressure (nephrotic syndrome)\n- Lymphatic obstruction\n\n---\n\n### ğŸ©¸ Thrombosis\n- **Virchowâ€™s Triad**: Endothelial injury, stasis, hypercoagulability\n- DVT â†’ PE risk\n\n---\n\n### ğŸš€ Embolism\n- Types: Thromboembolus, fat, air, amniotic\n- PE: Sudden SOB, death risk\n\n---\n\n### âš ï¸ Shock\n- Cardiogenic, hypovolemic, septic\n- â†“ Perfusion â†’ organ failure\n\n---\n\n### ğŸ§  Key Takeaway\nHemodynamic issues cause **ischemia, infarction, and death** if not corrected fast."
              },
              {
                "title": "Immunopathology",
                "description": "Hypersensitivity reactions, autoimmunity.",
                "notes": "### ğŸ›¡ï¸ Immunopathology\n\nDeals with **abnormal immune responses**.\n\n---\n\n### ğŸ¯ Hypersensitivity Types\n1. **Type I (Immediate)**: IgE, anaphylaxis, allergies\n2. **Type II (Cytotoxic)**: IgG/IgM vs cells (e.g. autoimmune hemolysis)\n3. **Type III (Immune Complex)**: SLE, serum sickness\n4. **Type IV (Delayed)**: T-cell mediated (TB test, dermatitis)\n\n---\n\n### ğŸ”„ Autoimmunity\n- Loss of self-tolerance â†’ attack on own tissue\n- e.g. SLE, RA, Hashimoto, T1DM\n\n---\n\n### ğŸ§  Key Takeaway\nImmunopathology explains many chronic illnesses via **exaggerated or misdirected immunity**."
              }
            ]
          },
          
          
          {
            "name": "Pharmacology",
            "topics": [
              {
                "title": "Pharmacokinetics",
                "description": "Absorption, distribution, metabolism, excretion (ADME).",
                "notes": "### âš—ï¸ Pharmacokinetics (PK)\n\nWhat the **body does to the drug** â€” determines onset, intensity, duration.\n\n---\n\n### ğŸ§ª ADME\n- **Absorption**: Entry into bloodstream (bioavailability â†“ by first-pass effect)\n- **Distribution**: Drug to tissues (Vd = apparent volume of distribution)\n- **Metabolism**: Usually in liver (Phase I â€“ oxidation/reduction; Phase II â€“ conjugation)\n- **Excretion**: Primarily renal; others: biliary, lungs, sweat\n\n---\n\n### ğŸ§  Key Takeaway\nPharmacokinetics explains how drug levels rise and fall â€” critical for **dosing** and **toxicity prevention**."
              },
              {
                "title": "Pharmacodynamics",
                "description": "Drug-receptor interactions and dose-response.",
                "notes": "### ğŸ¯ Pharmacodynamics (PD)\n\nWhat the **drug does to the body** â€” effect intensity and mechanism.\n\n---\n\n### ğŸ§¬ Receptor Types\n- Ion channels, GPCRs, enzyme-linked, nuclear\n\n### ğŸ§® Dose-Response Curve\n- **Potency**: Dose needed for effect\n- **Efficacy**: Max effect possible\n- **Therapeutic Index (TI)** = TD50 / ED50 (higher = safer)\n\n---\n\n### ğŸ§  Key Takeaway\nPharmacodynamics reveals **how drugs work**, **how strong**, and **how risky** they are."
              },
              {
                "title": "Autonomic Pharmacology",
                "description": "Drugs affecting sympathetic and parasympathetic systems.",
                "notes": "### ğŸ”Œ Autonomic Pharmacology\n\nTargets the **sympathetic and parasympathetic** nervous systems.\n\n---\n\n### ğŸ§  Receptor Classes\n- **Sympathetic** (Adrenergic): Î± (vasoconstriction), Î² (heart, lungs)\n- **Parasympathetic** (Cholinergic): Muscarinic (M1â€“M5), Nicotinic (N)\n\n---\n\n### ğŸ’Š Major Drug Classes\n- **Sympathomimetics**: Epi, norepi, albuterol\n- **Sympatholytics**: Î²-blockers, Î±-blockers\n- **Cholinomimetics**: ACh, pilocarpine, neostigmine\n- **Anticholinergics**: Atropine, ipratropium\n\n---\n\n### ğŸ§  Key Takeaway\nAutonomic drugs affect **BP, HR, GI, bladder, pupils** â€” common in **emergencies & chronic care**."
              },
              {
                "title": "Cardiovascular Drugs",
                "description": "Antihypertensives, antiarrhythmics, diuretics.",
                "notes": "### â¤ï¸ Cardiovascular Drugs\n\nCore treatments in **HTN, CHF, arrhythmias, angina**.\n\n---\n\n### ğŸ©º Classes\n- **Antihypertensives**:\n  - ACE inhibitors (enalapril)\n  - ARBs (losartan)\n  - Î²-blockers (metoprolol)\n  - CCBs (amlodipine)\n  - Diuretics (HCTZ, furosemide)\n\n- **Antiarrhythmics (Class Iâ€“IV)**:\n  - I: Naâº blockers\n  - II: Î²-blockers\n  - III: Kâº blockers\n  - IV: CCBs\n\n- **Nitrates**: Dilate coronary arteries (e.g. nitroglycerin)\n\n---\n\n### ğŸ§  Key Takeaway\nCardio drugs reduce **morbidity/mortality** â€” understanding their MOA = **life-saving practice**."
              },
              {
                "title": "Antibiotics",
                "description": "Mechanisms and classes of antibacterial agents.",
                "notes": "### ğŸ’Š Antibiotics\n\nDrugs that inhibit **bacterial growth (bacteriostatic)** or **kill bacteria (bactericidal)**.\n\n---\n\n### ğŸ”¬ Mechanisms\n1. **Cell wall synthesis**: Penicillins, cephalosporins\n2. **Protein synthesis**: Tetracyclines, macrolides, aminoglycosides\n3. **DNA/RNA synthesis**: Fluoroquinolones, rifampin\n4. **Metabolic pathways**: Sulfonamides, trimethoprim\n\n---\n\n### ğŸ“‰ Resistance Mechanisms\n- Î²-lactamase enzymes\n- Efflux pumps\n- Target site modification\n\n---\n\n### ğŸ§  Key Takeaway\nAntibiotics must be **chosen wisely** â€” misuse fuels **resistance**, failure, and **superbugs**."
              }
            ]
          },
          
          {
            "name": "Microbiology",
            "topics": [
              {
                "title": "Bacterial Structure and Classification",
                "description": "Basic features and Gram stain classification.",
                "notes": "### ğŸ¦  Bacterial Structure & Classification\n\nBacteria are prokaryotic, single-celled organisms with diverse shapes and properties.\n\n---\n\n### ğŸ”¬ Key Structures\n- **Cell wall**: Gram+ (thick peptidoglycan) vs Gramâ€“ (thin + outer membrane)\n- **Flagella**: Motility\n- **Pili (fimbriae)**: Adherence\n- **Capsule**: Anti-phagocytic\n- **Spores**: Dormant, resistant forms (e.g. *Bacillus*, *Clostridium*)\n\n---\n\n### ğŸ§ª Gram Stain\n- **Gram+**: Blue/purple (retain crystal violet)\n- **Gramâ€“**: Pink/red (safranin counterstain)\n\n---\n\n### ğŸ“Œ Shapes\n- **Cocci**: Round (e.g. *Staph*, *Strep*)\n- **Bacilli**: Rods (e.g. *E. coli*, *Bacillus*)\n- **Spirochetes**: Spiral (e.g. *Treponema*)\n\n---\n\n### ğŸ§  Key Takeaway\nStructure and stain type predict **pathogenicity**, **treatment**, and **diagnostic approach**."
              },
              {
                "title": "Viruses",
                "description": "DNA vs RNA viruses, replication, examples.",
                "notes": "### ğŸ¦  Viruses\n\nViruses are **obligate intracellular parasites** â€” they rely on host machinery to replicate.\n\n---\n\n### ğŸ§¬ Viral Genome\n- **DNA Viruses**: Mostly double-stranded (except parvo)\n- **RNA Viruses**: Mostly single-stranded (except reovirus)\n\n---\n\n### ğŸ” Replication Cycles\n1. Attachment\n2. Entry (endocytosis/fusion)\n3. Uncoating\n4. Replication\n5. Assembly\n6. Release (lysis or budding)\n\n---\n\n### ğŸ§ª Key Examples\n- **DNA**: Herpes, Hepatitis B, Parvovirus\n- **RNA**: Influenza, HIV, Coronavirus, Hepatitis C\n\n---\n\n### ğŸ§  Key Takeaway\nViral classification affects **replication strategy**, **transmission**, and **vaccine availability**."
              },
              {
                "title": "Fungi and Parasites",
                "description": "Common pathogenic fungi and protozoa.",
                "notes": "### ğŸ„ Fungi and Parasites\n\nEukaryotic organisms causing **chronic**, **opportunistic**, or **geographic** infections.\n\n---\n\n### ğŸ§« Fungi\n- **Yeasts**: Round, budding (e.g. *Candida*)\n- **Molds**: Filamentous, hyphae (e.g. *Aspergillus*)\n- **Dimorphic**: Yeast in body, mold in environment (*Histoplasma*)\n\n---\n\n### ğŸ¦  Parasites\n- **Protozoa**: Single-celled (e.g. *Plasmodium*, *Giardia*)\n- **Helminths**: Multicellular worms (e.g. *Ascaris*, *Schistosoma*)\n\n---\n\n### ğŸ§  Key Takeaway\nFungi and parasites show **slow growth**, **host evasion**, and often need **special stains or serology** for diagnosis."
              },
              {
                "title": "Sterilization and Disinfection",
                "description": "Principles and methods.",
                "notes": "### ğŸ§¼ Sterilization & Disinfection\n\nControl of microorganisms is critical in clinical and lab settings.\n\n---\n\n### ğŸ”’ Sterilization\n- Kills **all forms of life**, including spores\n- Methods:\n  - Autoclave (steam @ 121Â°C)\n  - Dry heat\n  - Gas (ethylene oxide)\n  - Radiation\n\n---\n\n### ğŸ’§ Disinfection\n- Reduces pathogen load (not necessarily spores)\n- High-level: Glutaraldehyde\n- Intermediate: Alcohol, iodine\n- Low-level: Phenolics, quats\n\n---\n\n### ğŸ§  Key Takeaway\n**Sterilization = complete kill**; **disinfection = pathogen reduction** â€” both vital for infection control."
              },
              {
                "title": "Vaccines",
                "description": "Types, schedules, and immune response.",
                "notes": "### ğŸ’‰ Vaccines\n\nVaccines **stimulate immunity** to prevent infectious diseases.\n\n---\n\n### ğŸ§¬ Types\n- **Live attenuated**: Strong, long-lasting (e.g. MMR, BCG)\n- **Inactivated**: Safer in immunocompromised (e.g. polio, hep A)\n- **Toxoid**: Inactivated toxins (e.g. tetanus, diphtheria)\n- **Subunit/conjugate**: Safer, require boosters (e.g. HPV, Hib)\n\n---\n\n### ğŸ“… Schedule\n- Childhood: BCG, OPV/IPV, DPT, Hep B, MMR, Hib, PCV\n- Boosters as per national guidelines\n\n---\n\n### ğŸ§  Key Takeaway\nVaccines are **preventive powerhouses**, saving millions by building **herd immunity** and reducing transmission."
              }
            ]
          },
          
          {
            "name": "Immunology",
            "topics": [
              {
                "title": "Innate and Adaptive Immunity",
                "description": "Key differences, cells, and functions.",
                "notes": "### ğŸ›¡ï¸ Innate vs Adaptive Immunity\n\nThe immune system protects against pathogens using **two tiers** of defense.\n\n---\n\n### âš¡ Innate Immunity\n- **Immediate**, non-specific\n- Cells: Neutrophils, macrophages, dendritic cells, NK cells\n- Barriers: Skin, mucosa\n- No memory\n\n### ğŸ§  Adaptive Immunity\n- **Delayed**, specific\n- B cells (â†’ plasma cells â†’ antibodies)\n- T cells (CD4+ helper, CD8+ cytotoxic)\n- **Has memory** â†’ faster second response\n\n---\n\n### ğŸ§  Key Takeaway\nInnate = rapid, no memory; Adaptive = slower, **highly specific**, with **lasting protection**."
              },
              {
                "title": "Antibodies and Antigens",
                "description": "Structure, classes, and antigen recognition.",
                "notes": "### ğŸ”— Antibodies & Antigens\n\nAntibodies (immunoglobulins) bind **antigens** to neutralize or tag them for destruction.\n\n---\n\n### ğŸ” Antibody Structure\n- 2 heavy + 2 light chains\n- Variable region = antigen-binding\n- Constant region = effector function (Fc)\n\n### ğŸ§¬ Ig Classes\n- **IgG**: Most abundant, crosses placenta\n- **IgA**: Mucosal, secretions\n- **IgM**: First made, pentamer\n- **IgE**: Allergies, parasites\n- **IgD**: B cell receptor (function unclear)\n\n---\n\n### ğŸ§  Key Takeaway\nAntibodies are the **tools** of humoral immunity â€” each type has **specific roles** in defense."
              },
              {
                "title": "Major Histocompatibility Complex (MHC)",
                "description": "Role of MHC I and II in antigen presentation.",
                "notes": "### ğŸ§¬ MHC: Antigen Presentation\n\nMHC molecules present antigen fragments to **T cells**.\n\n---\n\n### ğŸ“¦ MHC Classes\n- **MHC I**: On all nucleated cells\n  - Presents **endogenous antigens** (e.g. viral)\n  - Recognized by **CD8+ T cells**\n\n- **MHC II**: On APCs (macrophages, dendritic, B cells)\n  - Presents **exogenous antigens**\n  - Recognized by **CD4+ T cells**\n\n---\n\n### ğŸ§  Key Takeaway\nMHC is how the immune system **knows what to attack** â€” critical in infection, autoimmunity, and transplant rejection."
              },
              {
                "title": "Cytokines",
                "description": "Function and types of immune signaling molecules.",
                "notes": "### ğŸ“£ Cytokines\n\nCytokines are **messenger proteins** that coordinate immune responses.\n\n---\n\n### ğŸ”‘ Types & Functions\n- **IL-1, IL-6, TNF-Î±**: Fever, inflammation\n- **IL-2**: T cell proliferation\n- **IL-4, IL-5**: B cell and eosinophil activation\n- **IFN-Î³**: Macrophage activation, antiviral\n\n---\n\n### ğŸ§  Key Takeaway\nCytokines = **orchestrators** of immunity â€” small molecules with **massive regulatory power**."
              },
              {
                "title": "Immunodeficiencies",
                "description": "Primary vs secondary, examples, and implications.",
                "notes": "### ğŸš¨ Immunodeficiencies\n\nFailure of immune system â†’ **â†‘ susceptibility to infection and cancer**.\n\n---\n\n### ğŸ“Œ Types\n- **Primary**: Genetic\n  - SCID: â†“ T and B cells\n  - Bruton's: â†“ B cells\n  - DiGeorge: â†“ T cells (thymic aplasia)\n- **Secondary**: Acquired\n  - HIV/AIDS (â†“ CD4+)\n  - Malnutrition, chemo, splenectomy\n\n---\n\n### ğŸ§  Key Takeaway\nEarly diagnosis of immunodeficiency is crucial to **prevent life-threatening infections**."
              }
            ]
          }
          
        ]},
        {
          "year": 3,
          "subjects": [
            {
              "name": "Internal Medicine",
              "topics": [
                {
                  "title": "Hypertension",
                  "description": "Diagnosis, classification, and treatment of high blood pressure.",
                  "notes": "### ğŸ”´ Hypertension\n\nA chronic condition of persistently elevated **arterial blood pressure**.\n\n---\n\n### ğŸ“Š Classification (JNC 8 / ACC/AHA)\n- Normal: < 120/80 mmHg\n- Elevated: 120â€“129/<80\n- Stage 1 HTN: 130â€“139/80â€“89\n- Stage 2 HTN: â‰¥ 140/90\n\n---\n\n### ğŸ” Causes\n- **Primary (Essential)**: ~90% of cases\n- **Secondary**: Renal disease, endocrine, drugs\n\n---\n\n### âš™ï¸ Mechanisms\n- â†‘ Sympathetic tone\n- â†‘ RAAS activation\n- Endothelial dysfunction\n\n---\n\n### ğŸ’Š Treatment\n- Lifestyle: Diet, salt â†“, weight â†“\n- Medications:\n  - Thiazide diuretics\n  - ACE inhibitors / ARBs\n  - Calcium channel blockers\n  - Beta-blockers (selectively)\n\n---\n\n### ğŸ§  Key Takeaway\nEarly control of HTN **reduces stroke, MI, CKD**."
                },
                {
                  "title": "Diabetes Mellitus",
                  "description": "Types, pathophysiology, and management.",
                  "notes": "### ğŸ¬ Diabetes Mellitus\n\nA chronic metabolic disorder with **hyperglycemia** due to **insulin dysfunction**.\n\n---\n\n### ğŸ§¬ Types\n- **Type 1 DM**: Autoimmune destruction of Î²-cells â†’ absolute insulin deficiency\n- **Type 2 DM**: Insulin resistance + Î²-cell dysfunction\n\n---\n\n### ğŸ“‹ Diagnosis\n- FPG â‰¥ 126 mg/dL\n- HbA1c â‰¥ 6.5%\n- OGTT â‰¥ 200 mg/dL (2 hr)\n- Random glucose â‰¥ 200 mg/dL + symptoms\n\n---\n\n### ğŸ’‰ Management\n- **Type 1**: Insulin required\n- **Type 2**: Lifestyle + oral agents (metformin, SGLT2i, GLP-1RA)\n\n---\n\n### ğŸ§  Key Takeaway\nGlycemic control = â†“ complications: **retinopathy, nephropathy, neuropathy, macrovascular disease**"
                },
                {
                  "title": "COPD and Asthma",
                  "description": "Chronic respiratory disorders and their management.",
                  "notes": "### ğŸ« COPD & Asthma\n\nBoth are **obstructive airway diseases**, but with key differences.\n\n---\n\n### ğŸ«§ Asthma\n- Reversible bronchoconstriction\n- Triggers: Allergens, cold, exercise\n- Management: Inhaled corticosteroids, SABA/LABA\n\n### ğŸ’¨ COPD\n- Progressive, irreversible airflow limitation\n- Includes **chronic bronchitis** and **emphysema**\n- Risk: Smoking\n- Tx: Bronchodilators, ICS/LABA, oxygen, smoking cessation\n\n---\n\n### ğŸ§  Key Takeaway\nAsthma is **reversible and episodic**, COPD is **irreversible and progressive**."
                },
                {
                  "title": "Heart Failure",
                  "description": "Types, clinical features, investigations, and treatment.",
                  "notes": "### ğŸ’” Heart Failure\n\nHeart can't meet **circulatory demand** â†’ fluid overload + poor perfusion.\n\n---\n\n### ğŸ§¾ Types\n- **HFrEF**: EF < 40% (systolic)\n- **HFpEF**: EF â‰¥ 50% (diastolic)\n\n---\n\n### âš ï¸ Symptoms\n- Dyspnea, fatigue, orthopnea\n- Edema, JVD, rales\n\n---\n\n### ğŸ§ª Workup\n- BNP/NT-proBNP\n- ECG, Echo\n- CXR: Cardiomegaly, pulmonary congestion\n\n---\n\n### ğŸ’Š Management\n- Diuretics (symptom relief)\n- ACEi/ARB/ARNI\n- Beta-blockers\n- Aldosterone antagonists\n- SGLT2 inhibitors\n\n---\n\n### ğŸ§  Key Takeaway\nHF is managed with **neurohormonal blockade**, volume control, and **close monitoring**."
                },
                {
                  "title": "Infectious Diseases",
                  "description": "Common inpatient infections and antimicrobial strategies.",
                  "notes": "### ğŸ¦  Infectious Diseases (Inpatient)\n\nHospitalized patients commonly face **nosocomial and opportunistic infections**.\n\n---\n\n### âš¡ Common Infections\n- Pneumonia (CAP, HAP, VAP)\n- UTI/pyelonephritis\n- Cellulitis, abscess\n- Sepsis/bacteremia\n- Clostridioides difficile colitis\n\n---\n\n### ğŸ’‰ Empiric Antibiotic Principles\n- Start broad, then de-escalate\n- Use local antibiogram\n- Duration depends on site/severity\n\n---\n\n### ğŸ§  Key Takeaway\nPrompt recognition + targeted antibiotics = **â†“ mortality, â†“ resistance**."
                }
              ]
            },
            
            {
              "name": "General Surgery",
              "topics": [
                {
                  "title": "Appendicitis",
                  "description": "Presentation, diagnosis, and surgical treatment.",
                  "notes": "### âš ï¸ Appendicitis\n\n**Inflammation of the appendix** â€” the most common abdominal emergency.\n\n---\n\n### ğŸ“ Clinical Features\n- Periumbilical pain â†’ RLQ (McBurney's point)\n- Anorexia, nausea, low-grade fever\n- Rebound tenderness, Rovsingâ€™s sign, Psoas sign\n\n---\n\n### ğŸ§ª Diagnosis\n- CBC: â†‘ WBC\n- US (kids), CT scan (adults)\n\n---\n\n### ğŸ©º Treatment\n- **Appendectomy** (laparoscopic preferred)\n- IV fluids, analgesia, antibiotics\n\n---\n\n### ğŸ§  Key Takeaway\nEarly recognition & surgery prevent **rupture â†’ peritonitis**."
                },
                {
                  "title": "Hernias",
                  "description": "Types of hernias and surgical repair principles.",
                  "notes": "### ğŸ’ Hernias\n\nProtrusion of tissue through a weakness in the abdominal wall.\n\n---\n\n### ğŸ“Œ Types\n- **Inguinal (most common)**\n  - Indirect: Through inguinal canal (congenital)\n  - Direct: Through Hesselbachâ€™s triangle\n- **Femoral**: Below inguinal ligament (â†‘ strangulation risk)\n- **Umbilical, Incisional**\n\n---\n\n### ğŸ§ª Diagnosis\n- Physical exam\n- US/CT if uncertain\n\n---\n\n### ğŸ”§ Treatment\n- Surgical repair: Open or laparoscopic mesh repair\n\n---\n\n### ğŸ§  Key Takeaway\nAll symptomatic hernias â†’ **surgery**, especially if **incarcerated or strangulated**."
                },
                {
                  "title": "Gallbladder Disease",
                  "description": "Cholelithiasis, cholecystitis, and treatment.",
                  "notes": "### ğŸŸ¡ Gallbladder Disease\n\nIncludes **stones (cholelithiasis)** and **inflammation (cholecystitis)**.\n\n---\n\n### ğŸ§¾ Risk Factors\n- Female, Fat, Forty, Fertile\n\n---\n\n### ğŸ“Œ Presentations\n- Biliary colic: RUQ pain, post-fatty meal, resolves\n- Acute cholecystitis: Persistent pain, fever, Murphyâ€™s sign\n\n---\n\n### ğŸ§ª Workup\n- US: Stones, wall thickening, pericholecystic fluid\n- Labs: â†‘ WBC, mild â†‘ AST/ALT\n\n---\n\n### ğŸ©º Treatment\n- NPO, IV fluids, antibiotics\n- **Cholecystectomy** (laparoscopic preferred)\n\n---\n\n### ğŸ§  Key Takeaway\nAcute cholecystitis = urgent surgery; biliary colic = elective."
                },
                {
                  "title": "Thyroid Disorders",
                  "description": "Goiter, nodules, and surgical indications.",
                  "notes": "### ğŸ¦‹ Thyroid Disorders (Surgical)\n\nCommon surgical indications: **nodule, goiter, cancer suspicion**.\n\n---\n\n### ğŸ“Œ Goiter\n- Diffuse: Iodine deficiency, Graves\n- Multinodular: Toxic/non-toxic\n\n### ğŸ¯ Thyroid Nodule\n- FNA based on size/risk\n- US features: hypoechoic, irregular, microcalcifications â†’ higher malignancy\n\n---\n\n### ğŸ§ª Labs & Imaging\n- TSH, Free T4, US, +/- scintigraphy\n\n---\n\n### ğŸ”§ Surgery Indications\n- Suspicious/cancerous FNA\n- Compression symptoms\n- Toxic adenoma\n\n---\n\n### ğŸ§  Key Takeaway\nAlways evaluate nodule with **TSH + US + FNA** before considering surgery."
                },
                {
                  "title": "Trauma Management",
                  "description": "Initial assessment, ABCs, and surgical intervention.",
                  "notes": "### ğŸš¨ Trauma Management (ATLS)\n\nInitial priority in trauma = **life-threatening conditions**.\n\n---\n\n### ğŸ›¡ï¸ Primary Survey (ABCDE)\n- **A**irway with C-spine\n- **B**reathing\n- **C**irculation with hemorrhage control\n- **D**isability (GCS, pupils)\n- **E**xposure (undress, temperature)\n\n---\n\n### ğŸ” Secondary Survey\n- Head-to-toe assessment after stabilization\n\n### ğŸ“¸ Imaging\n- FAST exam\n- CXR, Pelvis XR\n\n---\n\n### ğŸ§  Key Takeaway\n**Early recognition + rapid intervention = survival.** Prioritize ABCs always."
                }
              ]
            },
            
            {
              "name": "Pediatrics",
              "topics": [
                {
                  "title": "Growth and Development",
                  "description": "Milestones and developmental screening.",
                  "notes": "### ğŸ“ˆ Growth & Development\n\nTracking physical and neurological development is **key to early detection of delays**.\n\n---\n\n### ğŸ“Š Milestones (Pareto Set)\n- **2 months**: Smiles, coos, lifts head\n- **6 months**: Sits, babbles, stranger anxiety\n- **12 months**: Walks, says 1â€“2 words\n- **18 months**: Scribbles, feeds self\n- **2 years**: 2-word phrases, runs, stacks 4 blocks\n- **3 years**: Tricycle, toilet training starts\n\n---\n\n### ğŸ“ Growth Curves\n- Weight doubles by 5â€“6 months, triples by 1 year\n- Use WHO <2 yrs, CDC â‰¥2 yrs\n\n---\n\n### ğŸ§  Key Takeaway\nEarly milestone tracking = **early intervention** for **autism, CP, language delays**."
                },
                {
                  "title": "Common Pediatric Infections",
                  "description": "Presentation and treatment of viral and bacterial infections.",
                  "notes": "### ğŸ¤’ Pediatric Infections (High-Yield)\n\nMost common: **respiratory, ear, GI, and viral exanthems**.\n\n---\n\n### ğŸ¦  Viral\n- **RSV bronchiolitis**: Wheezy infant, supportive care\n- **Influenza**: Fever, myalgia, oseltamivir if early\n- **Measles**: Cough, coryza, conjunctivitis + rash\n\n---\n\n### ğŸ§« Bacterial\n- **Otitis media**: Amoxicillin\n- **Strep pharyngitis**: Penicillin\n- **UTI**: E. coli; treat based on age, fever\n\n---\n\n### ğŸ§  Key Takeaway\nTreat **bacterial**, support **viral** â€” know **red flags**: toxic look, dehydration, persistent fever."
                },
                {
                  "title": "Childhood Nutrition",
                  "description": "Feeding guidelines, malnutrition, obesity.",
                  "notes": "### ğŸ Childhood Nutrition\n\nCrucial for **growth, cognition**, and **immune development**.\n\n---\n\n### ğŸ“… Feeding Guidelines\n- **Exclusive breastfeeding**: 0â€“6 months\n- **Start solids**: Around 6 months\n- **Whole milk**: Introduce after 12 months\n\n---\n\n### âš ï¸ Malnutrition\n- **Marasmus**: Calorie deficiency (wasted)\n- **Kwashiorkor**: Protein deficiency (edematous)\n\n### ğŸ“‰ Obesity\n- Screen with BMI >95th percentile\n- Prevent with diet, exercise, screen limits\n\n---\n\n### ğŸ§  Key Takeaway\n**Early nutrition** = foundation for **lifelong health** â€” balance under/overfeeding risks."
                },
                {
                  "title": "Pediatric Emergencies",
                  "description": "Febrile seizures, dehydration, asthma exacerbation.",
                  "notes": "### ğŸš¨ Pediatric Emergencies (Core Set)\n\nMost common emergencies: **seizure, breathing trouble, dehydration**.\n\n---\n\n### âš¡ Febrile Seizures\n- Age: 6 mo â€“ 5 yrs, tonic-clonic, <15 min\n- Workup if <1 yr or atypical\n- Tx: Antipyretics, reassurance\n\n### ğŸ’§ Dehydration\n- Signs: â†“ turgor, dry mucosa, sunken eyes\n- Tx: ORS if mild, IV NS if severe\n\n### ğŸ« Asthma Exacerbation\n- Sx: Wheeze, dyspnea, use of accessory muscles\n- Tx: Albuterol neb, steroids, Oâ‚‚\n\n---\n\n### ğŸ§  Key Takeaway\nPediatric emergencies = **speedy recognition** + **weight-based dosing** + **fluid support**."
                },
                {
                  "title": "Vaccination Schedule",
                  "description": "Recommended vaccines and timing.",
                  "notes": "### ğŸ’‰ Vaccination Schedule (Core)\n\nEssential to prevent **life-threatening infectious diseases**.\n\n---\n\n### ğŸ“… Key Vaccines by Age\n- **Birth**: BCG, Hep B\n- **6, 10, 14 weeks**: DPT, OPV/IPV, Hib, Hep B\n- **9 months**: Measles, yellow fever\n- **12â€“18 months**: MMR, PCV booster\n- **5 years**: DPT, polio boosters\n\n---\n\n### ğŸ§  Key Takeaway\nTimely vaccination = **herd immunity**, **public health cornerstone**, and **lifesaver** for children."
                }
              ]
            },
            
            {
              "name": "Obstetrics and Gynecology",
              "topics": [
                {
                  "title": "Antenatal Care",
                  "description": "Pregnancy monitoring and screening tests.",
                  "notes": "### ğŸ¤° Antenatal Care\n\nRegular care improves **maternal and fetal outcomes**.\n\n---\n\n### ğŸ“… Visit Schedule (Typical)\n- Monthly: Until 28 weeks\n- Biweekly: 28â€“36 weeks\n- Weekly: 36 weeks to delivery\n\n---\n\n### ğŸ§ª Screening\n- Blood group, Rh, CBC, HIV, Hep B, Syphilis\n- US for dating (1st tri), anomalies (2nd tri), growth (3rd)\n- GDM: OGTT at 24â€“28 weeks\n\n---\n\n### ğŸ§  Key Takeaway\nEarly & regular antenatal care detects **complications early** and supports **healthy pregnancy**."
                },
                {
                  "title": "Normal Labor and Delivery",
                  "description": "Stages of labor and delivery mechanisms.",
                  "notes": "### ğŸ‘¶ Labor and Delivery\n\nCoordinated uterine contractions leading to **expulsion of fetus and placenta**.\n\n---\n\n### ğŸ”„ Stages of Labor\n1. **Latent**: Onset to 6 cm dilation\n2. **Active**: 6 â†’ 10 cm\n3. **Second**: Full dilation â†’ delivery\n4. **Third**: Delivery â†’ placenta\n\n---\n\n### ğŸ§  Cardinal Movements\nEngagement â†’ Descent â†’ Flexion â†’ Internal Rotation â†’ Extension â†’ External Rotation â†’ Expulsion\n\n---\n\n### ğŸ§  Key Takeaway\nUnderstand labor stages to **monitor progression**, intervene when needed, and ensure **safe delivery**."
                },
                {
                  "title": "Postpartum Complications",
                  "description": "Bleeding, infection, depression.",
                  "notes": "### ğŸ¤± Postpartum Complications\n\nFirst 6 weeks = **puerperium** â€” monitor for **danger signs**.\n\n---\n\n### âš ï¸ Common Issues\n- **Hemorrhage**: Uterine atony most common (Tx: massage, oxytocin)\n- **Infection**: Endometritis, wound infection, mastitis\n- **Mental health**: Baby blues (resolves), **PP depression** (>2 weeks, Tx: therapy/SSRIs)\n\n---\n\n### ğŸ§  Key Takeaway\nPostpartum care = monitor bleeding, mood, and **support maternal health** during recovery."
                },
                {
                  "title": "Common Gynecological Conditions",
                  "description": "PCOS, fibroids, endometriosis.",
                  "notes": "### ğŸ§¬ Common Gynecologic Disorders\n\nChronic conditions affecting **fertility, bleeding, and pain**.\n\n---\n\n### âš ï¸ High-Yield Conditions\n- **PCOS**: Oligomenorrhea, hirsutism, insulin resistance\n- **Fibroids (leiomyoma)**: Heavy bleeding, pelvic mass\n- **Endometriosis**: Cyclic pelvic pain, dysmenorrhea, dyspareunia\n\n---\n\n### ğŸ” Diagnosis\n- US for fibroids/PCOS\n- Laparoscopy for endometriosis\n\n---\n\n### ğŸ§  Key Takeaway\nChronic GYN disorders are **hormonally influenced** and often affect **fertility or QoL**."
                },
                {
                  "title": "Contraception",
                  "description": "Types, effectiveness, indications.",
                  "notes": "### ğŸ›¡ï¸ Contraception\n\nWide range of options for **pregnancy prevention**, cycle control, and medical indications.\n\n---\n\n### ğŸ”¸ Methods\n- **Barrier**: Condoms (STI protection)\n- **Hormonal**: OCPs, patch, ring, injectable\n- **Long-acting**: IUD (hormonal/copper), implant\n- **Permanent**: Tubal ligation, vasectomy\n\n### ğŸ’¯ Effectiveness\n- Most effective: IUDs, implants\n- Least effective: Withdrawal, spermicide\n\n---\n\n### ğŸ§  Key Takeaway\nChoose contraception based on **efficacy, patient preference, comorbidities**."
                }
              ]
            },
            
            {
              "name": "Diagnostic Imaging",
              "topics": [
                {
                  "title": "X-Ray Interpretation",
                  "description": "Chest and abdominal radiograph basics.",
                  "notes": "### ğŸ“· X-Ray Interpretation (CXR & AXR)\n\nX-rays are **first-line** for many clinical scenarios.\n\n---\n\n### ğŸ” Chest X-Ray (CXR) â€” ABCDE Approach\n- **A**irway: Trachea midline\n- **B**ones: Clavicles, ribs, spine\n- **C**ardiac: Size <50% (PA view)\n- **D**iaphragm: Costophrenic angles clear\n- **E**verything else: Lung fields, devices\n\n---\n\n### ğŸ©º Common Findings\n- Consolidation â†’ pneumonia\n- Hyperinflation â†’ COPD/asthma\n- Pleural effusion â†’ blunting\n\n---\n\n### âš™ï¸ Abdominal X-Ray (AXR)\n- Use for obstruction, perforation\n- Look for air-fluid levels, free air\n\n---\n\n### ğŸ§  Key Takeaway\nSystematic reading of X-rays helps catch **life-threatening pathology quickly**."
                },
                {
                  "title": "Ultrasound Principles",
                  "description": "Indications, strengths, and limitations.",
                  "notes": "### ğŸ§ª Ultrasound (US) Basics\n\nUses **sound waves** to visualize **soft tissues** in real-time.\n\n---\n\n### âœ… Strengths\n- Safe: No radiation\n- Bedside availability (POCUS)\n- Visualize fluid, vessels, fetal structures\n\n### âš ï¸ Limitations\n- Operator-dependent\n- Poor for air or bone-containing structures\n\n---\n\n### ğŸ“Œ Indications\n- **Obstetrics**: Fetal age, position, viability\n- **Abdomen**: Gallstones, kidney, free fluid (FAST)\n- **Vascular**: DVT, carotids\n\n---\n\n### ğŸ§  Key Takeaway\nUltrasound = **safe, versatile, first-line tool** in many settings."
                },
                {
                  "title": "CT and MRI",
                  "description": "When to order, safety, interpretation basics.",
                  "notes": "### ğŸ§  CT & MRI\n\nAdvanced imaging used for **internal detail** and **complex pathology**.\n\n---\n\n### ğŸ–¼ï¸ CT Scan\n- Uses X-rays, cross-sectional\n- **Fast**, great for bone, blood, lungs\n- Caution: Radiation + contrast nephropathy\n\n### ğŸ§² MRI\n- Uses magnetic fields, no radiation\n- **Best for soft tissue**: Brain, spine, joints\n- Caution: Time, cost, metal implants\n\n---\n\n### ğŸ“Œ Use Cases\n- **CT Head**: Bleed, trauma\n- **CT Chest/Abdomen**: PE, tumors, trauma\n- **MRI Brain/Spine**: Tumors, MS, disc disease\n\n---\n\n### ğŸ§  Key Takeaway\nCT = fast, trauma-focused. MRI = detailed, neuro/muscle-focus. Pick based on **speed vs detail**."
                }
              ]
            },
            
            {
              "name": "Clinical Skills",
              "topics": [
                {
                  "title": "History Taking",
                  "description": "Structure of a comprehensive medical history.",
                  "notes": "### ğŸ—£ï¸ History Taking\n\nFoundational for diagnosis â€” effective history = 80% of diagnosis.\n\n---\n\n### ğŸ“‹ Basic Structure\n- **Chief Complaint** (CC)\n- **History of Present Illness (HPI)**: Onset, location, duration, character, alleviating/aggravating factors\n- **Past Medical History (PMH)**\n- **Medications & Allergies**\n- **Family History (FH)**\n- **Social History (SH)**: Smoking, alcohol, occupation\n- **Review of Systems (ROS)**\n\n---\n\n### ğŸ§  Key Takeaway\nA focused, empathetic history = **faster diagnosis**, stronger **patient trust**."
                },
                {
                  "title": "Physical Examination",
                  "description": "Head-to-toe exam basics, special tests.",
                  "notes": "### ğŸ‘¨â€âš•ï¸ Physical Exam\n\nObjective evaluation of health status â€” done **systematically**.\n\n---\n\n### ğŸ©º General Flow\n1. **General appearance**\n2. **Vital signs** (T, BP, HR, RR, Oâ‚‚)\n3. **HEENT**, **Neck** (thyroid, lymph)\n4. **Chest/lungs**: Inspection, percussion, auscultation\n5. **CVS**: Heart sounds, JVP, pulses\n6. **Abdomen**: Inspection â†’ palpation â†’ percussion â†’ auscultation\n7. **Neuro exam**: Reflexes, strength, cranial nerves\n\n---\n\n### ğŸ§  Key Takeaway\nAlways **observe, inspect, palpate, percuss, auscultate** â€” in that order!"
                },
                {
                  "title": "ECG Interpretation",
                  "description": "Reading rhythm strips and common patterns.",
                  "notes": "### â¤ï¸ ECG Interpretation\n\nRapid, non-invasive cardiac assessment.\n\n---\n\n### ğŸªœ Step-by-Step\n1. **Rate**: 300 Ã· big squares between R waves\n2. **Rhythm**: Regular? P waves present?\n3. **Axis**: Normal = lead I & aVF both â†‘\n4. **P waves**: Atrial activity\n5. **PR/QRS/QT intervals**: Check duration\n6. **ST/T waves**: Ischemia or injury?\n\n---\n\n### âš ï¸ Common Pathologies\n- **ST Elevation**: MI\n- **AFib**: Irregularly irregular, no P\n- **Heart Block**: Prolonged PR, dropped beats\n\n---\n\n### ğŸ§  Key Takeaway\nMaster ECG by repetition â€” start with **rate, rhythm, intervals**, then patterns."
                },
                {
                  "title": "Basic Procedures",
                  "description": "IV insertion, catheterization, blood draw.",
                  "notes": "### ğŸ’‰ Basic Clinical Procedures\n\nHands-on tasks every doctor must master.\n\n---\n\n### ğŸ§ª Core Skills\n- **IV Cannulation**: Tourniquet â†’ alcohol â†’ bevel up â†’ secure\n- **Urinary Catheterization**: Sterile technique, balloon inflation\n- **Venipuncture**: Median cubital vein, label tubes\n- **Blood Culture**: Use separate site + antisepsis\n\n---\n\n### âš ï¸ Tips\n- Always **confirm identity**, explain procedure\n- Use **PPE**, maintain **asepsis**\n\n---\n\n### ğŸ§  Key Takeaway\nProcedures = **practice, preparation**, and **patient comfort** â€” never skip the checklist!"
                }
              ]
            }
            
          ]
        },
        
        {
          "year": 4,
          "subjects": [
            {
              "name": "Neurology",
              "topics": [
                {
                  "title": "Stroke",
                  "description": "Types, symptoms, diagnosis, and acute management.",
                  "notes": "### ğŸ§  Stroke\n\nSudden neurologic deficit due to **ischemia or hemorrhage**.\n\n---\n\n### âš¡ Types\n- **Ischemic (85%)**: Thrombotic, embolic\n- **Hemorrhagic (15%)**: ICH, SAH\n\n### ğŸ§¾ Symptoms\n- FAST: Face droop, Arm weakness, Speech slurred, Time critical\n- Hemiparesis, aphasia, vision loss\n\n### ğŸ§ª Workup\n- **CT Head (non-contrast)**: Rule out bleed\n- MRI for early ischemia\n- ECG, carotid US, echo\n\n---\n\n### ğŸ’‰ Management\n- Ischemic: **tPA** if <4.5 hr, thrombectomy\n- Hemorrhagic: BP control, neurosurg eval\n\n---\n\n### ğŸ§  Key Takeaway\nStroke = **emergency** â€” time is brain! Act fast, scan early, and **reperfuse or protect**."
                },
                {
                  "title": "Seizures and Epilepsy",
                  "description": "Classification, diagnosis, and treatment.",
                  "notes": "### âš¡ Seizures & Epilepsy\n\n**Seizure** = transient electrical brain event. **Epilepsy** = 2+ unprovoked seizures.\n\n---\n\n### ğŸ“Œ Types\n- **Focal**: One hemisphere (aware or impaired)\n- **Generalized**: Bilateral (tonic-clonic, absence)\n\n### ğŸ§ª Workup\n- EEG, MRI brain\n- Labs: glucose, electrolytes, toxins\n\n### ğŸ’Š Treatment\n- 1st line: **Levetiracetam**, phenytoin, valproate\n- Status epilepticus: Benzos first â†’ phenytoin\n\n---\n\n### ğŸ§  Key Takeaway\nDifferentiate types â†’ tailor treatment â†’ watch for **status epilepticus**!"
                },
                {
                  "title": "Headache Disorders",
                  "description": "Migraine, tension, cluster headache features and treatment.",
                  "notes": "### ğŸ¤• Headache Disorders\n\nMost headaches are benign â€” ID **red flags** to rule out danger.\n\n---\n\n### ğŸ§  Primary Headaches\n- **Migraine**: Pulsatile, unilateral, photophobia, +/- aura (Tx: triptans)\n- **Tension**: Band-like, bilateral, stress-linked (Tx: NSAIDs)\n- **Cluster**: Severe, periorbital, lacrimation, same time daily (Tx: Oâ‚‚, triptans)\n\n### ğŸš¨ Red Flags (SNOOP)\n- Systemic signs\n- Neuro deficits\n- Onset sudden (thunderclap)\n- Older age\n- Pattern change\n\n---\n\n### ğŸ§  Key Takeaway\nHeadache + neuro signs â†’ **scan brain**. Migraine = **functional**, cluster = **excruciating**, tension = **common**."
                },
                {
                  "title": "Neuro Exam",
                  "description": "Cranial nerves, motor/sensory, gait.",
                  "notes": "### ğŸ§  Neurological Exam\n\nStructured exam = localization of neuro lesions.\n\n---\n\n### ğŸ” Components\n- **Cranial Nerves (CN Iâ€“XII)**: Vision, facial symmetry, tongue, swallow\n- **Motor**: Strength, tone, reflexes\n- **Sensory**: Light touch, pinprick, proprioception\n- **Cerebellar**: Finger-nose, heel-shin, Romberg\n- **Gait**: Normal, tandem, toe/heel walk\n\n---\n\n### ğŸ§  Key Takeaway\nNeuro exam helps pinpoint **CNS vs PNS** issues â€” practice makes precision."
                }
              ]
            },
            
            {
              "name": "Psychiatry",
              "topics": [
                {
                  "title": "Depression and Mood Disorders",
                  "description": "Major depressive disorder, bipolar disorder.",
                  "notes": "### ğŸ˜” Depression & Mood Disorders\n\nAffect **mood, energy, and function** â€” common and treatable.\n\n---\n\n### ğŸ§  Major Depressive Disorder (MDD)\n- â‰¥2 weeks of: Depressed mood or anhedonia + â‰¥4 SIGECAPS (Sleep, Interest, Guilt, Energy, Concentration, Appetite, Psychomotor, Suicidality)\n- Must cause functional impairment\n\n### ğŸ” Bipolar Disorder\n- **Bipolar I**: â‰¥1 manic episode (with or without depression)\n- **Bipolar II**: Hypomania + depression\n\n### ğŸ’Š Treatment\n- Depression: SSRIs (e.g. sertraline)\n- Bipolar: Mood stabilizers (lithium, valproate), antipsychotics\n\n---\n\n### ğŸ§  Key Takeaway\nMood disorders vary in intensity â€” **screen early**, **treat promptly**."
                },
                {
                  "title": "Anxiety Disorders",
                  "description": "GAD, panic, phobias, PTSD.",
                  "notes": "### ğŸ˜Ÿ Anxiety Disorders\n\nExcessive fear or worry with **functional impact**.\n\n---\n\n### ğŸ“Œ Types\n- **GAD**: Chronic worry + muscle tension, insomnia\n- **Panic Disorder**: Recurrent attacks + fear of recurrence\n- **Phobias**: Specific object/situation avoidance\n- **PTSD**: After trauma: intrusive memories, avoidance, hyperarousal\n\n---\n\n### ğŸ’Š Management\n- CBT = first-line for all\n- SSRIs/SNRIs (e.g. sertraline, venlafaxine)\n- Benzos short-term only\n\n---\n\n### ğŸ§  Key Takeaway\nRule out medical causes (e.g. hyperthyroid) â€” anxiety is **high-prevalence, high-impact**."
                },
                {
                  "title": "Psychosis and Schizophrenia",
                  "description": "Symptoms, diagnosis, antipsychotic meds.",
                  "notes": "### ğŸ§© Psychosis & Schizophrenia\n\nPsychosis = loss of **reality testing** â€” hallucinations, delusions, disorganized thought.\n\n---\n\n### ğŸ§  Schizophrenia\n- â‰¥6 months of disturbance, with â‰¥1 month active symptoms\n- Positive symptoms: Delusions, hallucinations\n- Negative: Flat affect, avolition\n\n### ğŸ“Š Subtypes\n- Brief psychotic (<1 month)\n- Schizophreniform (<6 months)\n\n### ğŸ’Š Treatment\n- Antipsychotics:\n  - Typical: Haloperidol (â†‘ EPS risk)\n  - Atypical: Risperidone, olanzapine (metabolic risk)\n\n---\n\n### ğŸ§  Key Takeaway\nSchizophrenia = **chronic, functional loss** â†’ long-term meds + psychosocial support."
                },
                {
                  "title": "Substance Use Disorders",
                  "description": "Alcohol, opioids, stimulants.",
                  "notes": "### ğŸ· Substance Use Disorders\n\nCompulsive use despite harm â€” chronic relapsing brain disease.\n\n---\n\n### âš¡ Key Substances\n- **Alcohol**: Withdrawal â†’ tremors, seizures, delirium tremens\n- **Opioids**: Pinpoint pupils, respiratory depression; withdrawal = yawning, lacrimation\n- **Stimulants**: Euphoria, tachycardia, paranoia (e.g. cocaine, amphetamines)\n\n---\n\n### ğŸ©º Management\n- Alcohol: Benzos, thiamine, naltrexone\n- Opioids: Naloxone (OD), methadone/buprenorphine (maintenance)\n- Stimulants: Supportive, CBT\n\n---\n\n### ğŸ§  Key Takeaway\nTreat **withdrawal safely**, support **recovery** â€” harm reduction saves lives."
                }
              ]
            },
            
            {
              "name": "Dermatology",
              "topics": [
                {
                  "title": "Skin Lesion Identification",
                  "description": "Macule, papule, vesicle, etc.",
                  "notes": "### ğŸ” Skin Lesion Basics\n\nIdentify by **size, shape, color, contents**.\n\n---\n\n### ğŸ§± Primary Lesions\n- **Macule**: Flat, <1 cm (e.g. freckle)\n- **Papule**: Raised, <1 cm (e.g. acne)\n- **Plaque**: Raised, >1 cm (e.g. psoriasis)\n- **Vesicle**: Fluid-filled, <1 cm (e.g. HSV)\n- **Bulla**: Fluid-filled, >1 cm (e.g. blister)\n- **Pustule**: Pus-filled (e.g. folliculitis)\n- **Nodule**: Solid, deep, >1 cm\n\n---\n\n### ğŸ§  Key Takeaway\nKnowing basic lesion types helps with **diagnosis and documentation**."
                },
                {
                  "title": "Common Skin Conditions",
                  "description": "Acne, eczema, psoriasis, urticaria.",
                  "notes": "### ğŸŒ¿ Common Derm Conditions\n\nChronic, inflammatory, or immune skin disorders.\n\n---\n\n### ğŸ“Œ Key Disorders\n- **Acne vulgaris**: Comedones, pustules; tx: retinoids, benzoyl, abx\n- **Eczema (AD)**: Pruritic, flexural, dry; tx: emollients, steroids\n- **Psoriasis**: Silvery plaques, extensor; tx: steroids, vit D, biologics\n- **Urticaria**: Transient wheals; tx: antihistamines\n\n---\n\n### ğŸ§  Key Takeaway\nMost rashes respond to **moisture, steroids, antihistamines** â€” tailor based on **pattern and triggers**."
                },
                {
                  "title": "Skin Infections",
                  "description": "Bacterial, fungal, viral.",
                  "notes": "### ğŸ§« Skin Infections\n\nClassified by **cause and depth**.\n\n---\n\n### ğŸ¦  Bacterial\n- Impetigo (S. aureus): Honey crust, mupirocin/oral abx\n- Cellulitis: Red, warm, tender, usually S. aureus/Strep; tx: flucloxacillin\n\n### ğŸ„ Fungal\n- Tinea: Ringworm (corporis, pedis); tx: topical azoles\n- Candida: Intertriginous, oral thrush\n\n### ğŸ¦  Viral\n- HSV: Vesicles on erythematous base\n- Varicella/Zoster: Dewdrops â†’ crust\n\n---\n\n### ğŸ§  Key Takeaway\nID the **pathogen type**, **treat early**, **prevent spread** â€” use topicals or orals as needed."
                },
                {
                  "title": "Skin Cancer Basics",
                  "description": "Basal, squamous, melanoma overview.",
                  "notes": "### â˜€ï¸ Skin Cancer Overview\n\nCaused by **UV exposure** + genetics â€” early detection saves lives.\n\n---\n\n### ğŸ§¬ Types\n- **Basal Cell Carcinoma (BCC)**: Pearly papule, telangiectasia, slow-growing\n- **Squamous Cell Carcinoma (SCC)**: Crusty ulcer/plaque, sun-exposed, can metastasize\n- **Melanoma**: Irregular mole; ABCDE (Asymmetry, Border, Color, Diameter >6mm, Evolving)\n\n---\n\n### ğŸ§ª Diagnosis\n- Dermoscopy\n- Biopsy (punch/excisional)\n\n---\n\n### ğŸ§  Key Takeaway\n**ABCDE** criteria + sun history â†’ suspect melanoma â†’ **urgent biopsy**."
                }
              ]
            },
            
            {
              "name": "Emergency Medicine",
              "topics": [
                {
                  "title": "ABC Assessment and Resuscitation",
                  "description": "Primary survey and stabilization approach.",
                  "notes": "### ğŸ†˜ ABC Assessment (Primary Survey)\n\nCore of **Advanced Trauma Life Support (ATLS)** â€” prioritize life threats.\n\n---\n\n### ğŸ”¤ ABCDE Steps\n- **A**irway + cervical spine protection\n- **B**reathing: Check RR, symmetry, Oâ‚‚\n- **C**irculation: Pulse, BP, bleeding, IV access\n- **D**isability: GCS, pupils, glucose\n- **E**xposure: Full exam, prevent hypothermia\n\n---\n\n### ğŸ§  Key Takeaway\nABCs first in **every emergency** â€” correct immediate threats **before detailed diagnosis**."
                },
                {
                  "title": "Shock Types and Management",
                  "description": "Hypovolemic, septic, anaphylactic, cardiogenic.",
                  "notes": "### âš¡ Shock: Types & Treatment\n\nShock = **inadequate tissue perfusion** â†’ organ failure.\n\n---\n\n### ğŸ” Types\n- **Hypovolemic**: Hemorrhage, dehydration (Tx: fluids)\n- **Cardiogenic**: MI, arrhythmia (Tx: inotropes)\n- **Septic**: Infection + vasodilation (Tx: fluids + abx)\n- **Anaphylactic**: Allergy, histamine surge (Tx: **epinephrine IM**)\n\n---\n\n### ğŸ§ª Diagnosis\n- Lactate â†‘, BP â†“, tachycardia\n- Look for underlying cause\n\n---\n\n### ğŸ§  Key Takeaway\nRecognize type fast â†’ restore perfusion â†’ treat cause â†’ **monitor vitals & urine output**."
                },
                {
                  "title": "Acute Chest Pain",
                  "description": "MI, PE, dissection, pneumothorax.",
                  "notes": "### â¤ï¸ Acute Chest Pain\n\nNot all chest pain is cardiac â€” **recognize killers** early.\n\n---\n\n### âš ï¸ 5 Must-Not-Miss Diagnoses\n- **MI**: Crushing, radiates to arm/jaw (ECG, troponin)\n- **PE**: Pleuritic, SOB, tachycardia (D-dimer, CT-PA)\n- **Aortic Dissection**: Tearing pain, pulse deficit (CTA, BP diff)\n- **Pneumothorax**: Sudden, unilateral, â†“ breath sounds (CXR)\n- **Pericarditis/Tamponade**: Positional pain, muffled heart sounds (Echo)\n\n---\n\n### ğŸ§  Key Takeaway\nDo **ECG + troponin + CXR + vitals** first â†’ stabilize, then image if needed."
                },
                {
                  "title": "Poisoning and Overdose",
                  "description": "Common toxidromes and treatments.",
                  "notes": "### â˜ ï¸ Poisoning & Overdose\n\nEmergency diagnosis by **toxidrome patterns**.\n\n---\n\n### ğŸ” Toxidromes\n- **Opioids**: Pinpoint pupils, â†“ RR â†’ naloxone\n- **Anticholinergic**: Hot, dry, blind, red, mad â†’ physostigmine (rare)\n- **Cholinergic (organophosphates)**: Salivation, diarrhea â†’ atropine + pralidoxime\n- **Sympathomimetic**: Tachycardia, agitation â†’ benzos, fluids\n\n---\n\n### ğŸ’‰ Universal Measures\n- ABCs, activated charcoal (if early), antidote if known\n- Monitor ECG, glucose, electrolytes\n\n---\n\n### ğŸ§  Key Takeaway\nUse the **toxidrome** to guide **antidote** â€” always stabilize airway and vitals first."
                }
              ]
            },
            
            {
              "name": "Obstetrics & Gynecology (Advanced)",
              "topics": [
                {
                  "title": "High-Risk Pregnancy",
                  "description": "Gestational diabetes, hypertension, preterm labor.",
                  "notes": "### âš ï¸ High-Risk Pregnancy\n\nConditions that increase **maternal or fetal complications**.\n\n---\n\n### ğŸ§ª Key Conditions\n- **Gestational Diabetes**: Screen @ 24â€“28 wks (OGTT)\n  - Tx: Diet, insulin\n- **Gestational Hypertension**: BP â‰¥ 140/90 after 20 weeks\n- **Preeclampsia**: HTN + proteinuria/organ damage\n  - Severe: â†‘ BP, headache, vision changes\n  - Tx: MgSOâ‚„ (seizure prophylaxis), delivery if term\n- **Preterm Labor**: <37 wks + contractions + cervix changes\n  - Tx: Tocolytics, steroids\n\n---\n\n### ğŸ§  Key Takeaway\nMonitor closely, manage actively â€” aim for **safe timing of delivery**."
                },
                {
                  "title": "Fetal Monitoring",
                  "description": "CTG interpretation and prenatal assessment.",
                  "notes": "### ğŸ“‰ Fetal Monitoring (CTG & Beyond)\n\nAssesses fetal well-being before and during labor.\n\n---\n\n### ğŸ“‹ CTG (Cardiotocography)\n- **Baseline HR**: 110â€“160 bpm\n- **Variability**: 6â€“25 bpm = reassuring\n- **Accelerations**: Normal, reactive\n- **Decelerations**:\n  - Early = head compression\n  - Variable = cord\n  - Late = placental insufficiency (bad)\n\n### ğŸ§ª Other Tools\n- Biophysical profile (BPP)\n- Doppler flow studies (IUGR)\n\n---\n\n### ğŸ§  Key Takeaway\nCTG = **noninvasive window** into fetal status â€” act fast with **non-reassuring patterns**."
                },
                {
                  "title": "Gynecological Cancers",
                  "description": "Cervical, ovarian, endometrial basics.",
                  "notes": "### ğŸ§¬ GYN Cancers Overview\n\nOften present late â€” screening and suspicion are key.\n\n---\n\n### ğŸ“ Cervical Cancer\n- HPV-related (16, 18)\n- Screen: Pap smear + HPV testing\n- Tx: LEEP, hysterectomy, chemorads\n\n### ğŸ“ Ovarian Cancer\n- Silent, adnexal mass, â†‘ CA-125\n- Tx: Surgery + chemo\n\n### ğŸ“ Endometrial Cancer\n- Postmenopausal bleeding\n- Risk: Obesity, unopposed estrogen\n- Dx: Endometrial biopsy\n\n---\n\n### ğŸ§  Key Takeaway\n**Early signs = early cure** â€” understand risk factors and screening guidelines."
                }
              ]
            },
            
            {
              "name": "Clinical Ethics and Communication",
              "topics": [
                {
                  "title": "Informed Consent",
                  "description": "Legal and ethical considerations.",
                  "notes": "### ğŸ“ Informed Consent\n\nLegal + ethical duty to ensure patients make **informed, voluntary decisions**.\n\n---\n\n### âœ… Elements of Valid Consent\n1. **Capacity**: Patient can understand/decide\n2. **Information**: Nature, risks, alternatives, consequences\n3. **Voluntariness**: No coercion\n4. **Understanding & agreement**\n\n---\n\n### ğŸ§  Exceptions\n- Emergencies\n- Minors (some cases)\n- Court-ordered treatment\n\n---\n\n### ğŸ§  Key Takeaway\nConsent is not just a form â€” it's a **conversation** that builds **trust and autonomy**."
                },
                {
                  "title": "Breaking Bad News",
                  "description": "SPIKES protocol and sensitive communication.",
                  "notes": "### ğŸ’¬ Breaking Bad News (SPIKES)\n\nDelivering difficult news with **clarity, empathy, and support**.\n\n---\n\n### ğŸ§± SPIKES Protocol\n- **S**etting: Private, comfortable\n- **P**erception: What does the patient know?\n- **I**nvitation: How much do they want to know?\n- **K**nowledge: Provide info clearly\n- **E**motions: Acknowledge, support\n- **S**trategy: Next steps, questions\n\n---\n\n### ğŸ§  Key Takeaway\nUse SPIKES to **honor emotions**, **maintain clarity**, and **offer support**."
                },
                {
                  "title": "End-of-Life Care",
                  "description": "Palliative care principles, DNR, advanced directives.",
                  "notes": "### ğŸ•Šï¸ End-of-Life Care\n\nFocus on **comfort, dignity**, and **family support** â€” not cure.\n\n---\n\n### ğŸŒ¼ Palliative Principles\n- Symptom control: Pain, nausea, breathlessness\n- Psychological, spiritual, family support\n- Clear communication on goals\n\n### ğŸ“‹ DNR & Advance Directives\n- Respect patient autonomy\n- Clarify before deterioration\n- Document preferences and power of attorney\n\n---\n\n### ğŸ§  Key Takeaway\nGood EOL care = **less suffering**, **more dignity**, and **patient-centered decisions**."
                }
              ]
            }
            
          ]
        },        
        {
          "year": 5,
          "subjects": [
            {
              "name": "Internal Medicine (Advanced)",
              "topics": [
                {
                  "title": "Rheumatology",
                  "description": "Basics of autoimmune diseases: RA, lupus, spondyloarthropathies.",
                  "notes": "### ğŸ¤² Rheumatology Essentials\n\nFocuses on **autoimmune and inflammatory disorders** affecting joints and organs.\n\n---\n\n### ğŸ”¥ Key Conditions\n- **Rheumatoid Arthritis (RA)**: Symmetric small joint pain, â†‘ RF/anti-CCP, erosions on X-ray; Tx: methotrexate\n- **Systemic Lupus Erythematosus (SLE)**: Malar rash, photosensitivity, nephritis, +ANA/dsDNA; Tx: hydroxychloroquine, steroids\n- **Spondyloarthropathies**: HLA-B27+, includes AS, PsA, IBD arthritis; Tx: NSAIDs, biologics\n\n---\n\n### ğŸ§  Key Takeaway\nAutoimmune diseases = systemic, chronic â†’ require **early diagnosis, immunosuppressive treatment**."
                },
                {
                  "title": "Renal Disorders",
                  "description": "AKI vs CKD, glomerulonephritis, nephrotic/nephritic.",
                  "notes": "### ğŸ©¸ Renal Disorders\n\nKidney diseases classified by **acute vs chronic**, and **glomerular syndromes**.\n\n---\n\n### ğŸ†˜ AKI vs CKD\n- **AKI**: Rapid â†‘ creatinine, â†“ urine; pre-, intra-, post-renal causes\n- **CKD**: Gradual decline over â‰¥3 months, GFR staging\n\n### ğŸ” Glomerular Syndromes\n- **Nephrotic**: Proteinuria >3.5g, edema, hypoalbumin (e.g. MCD, FSGS)\n- **Nephritic**: Hematuria, HTN, oliguria (e.g. PSGN, RPGN)\n\n---\n\n### ğŸ§  Key Takeaway\nAlways assess **urinalysis + creatinine + BP** â†’ guides further nephrology workup."
                },
                {
                  "title": "Endocrine Disorders",
                  "description": "Thyroid, adrenal, pituitary diseases.",
                  "notes": "### ğŸ§¬ Endocrine Disorders\n\nDiseases of **hormone-producing glands** â€” can be hypo- or hyper-functioning.\n\n---\n\n### ğŸ“Œ Thyroid\n- **Hypothyroid**: Fatigue, weight gain, cold intolerance (â†‘ TSH)\n- **Hyperthyroid**: Weight loss, tremor, heat intolerance (â†“ TSH)\n\n### ğŸ“Œ Adrenal\n- **Addisonâ€™s**: â†“ cortisol/aldosterone â†’ fatigue, hypotension, hyperpigmentation\n- **Cushingâ€™s**: â†‘ cortisol â†’ obesity, moon face, striae\n\n### ğŸ“Œ Pituitary\n- Prolactinoma (galactorrhea), acromegaly, diabetes insipidus\n\n---\n\n### ğŸ§  Key Takeaway\nHormonal imbalances â†’ **multi-system effects** â€” labs + imaging crucial."
                },
                {
                  "title": "GI and Liver Disease",
                  "description": "IBD, hepatitis, cirrhosis, peptic ulcer.",
                  "notes": "### ğŸ½ï¸ GI & Liver Pathology\n\nIncludes inflammatory, infectious, and structural diseases.\n\n---\n\n### ğŸ”¥ Inflammatory Bowel Disease\n- **Crohnâ€™s**: Skip lesions, full-thickness, any GI part\n- **UC**: Colon-only, continuous, mucosal\n\n### ğŸ¦  Hepatitis & Cirrhosis\n- Viral (Aâ€“E), alcoholic, NAFLD\n- Cirrhosis: Portal HTN, ascites, varices, HCC risk\n\n### ğŸ©¹ Peptic Ulcer\n- H. pylori, NSAIDs; pain relieved/worsened by food\n\n---\n\n### ğŸ§  Key Takeaway\nGI complaints = rule out red flags: **bleeding, weight loss, anemia**, and treat **early**."
                }
              ]
            },
            
            {
              "name": "Surgery (Advanced)",
              "topics": [
                {
                  "title": "Surgical Oncology",
                  "description": "Principles of tumor resection, lymph node clearance.",
                  "notes": "### ğŸ¯ Surgical Oncology\n\nFocuses on **resecting malignancies** and preventing spread.\n\n---\n\n### ğŸ› ï¸ Key Principles\n- **Wide excision** with margins\n- **Lymph node dissection**: Sentinel or complete\n- Tumor staging (TNM) guides extent\n\n### ğŸ§ª Adjuncts\n- Neoadjuvant chemo/rads: Shrink before surgery\n- Adjuvant therapy: After resection\n\n---\n\n### ğŸ§  Key Takeaway\nGoal = **complete resection**, minimize recurrence â†’ depends on **stage and type**."
                },
                {
                  "title": "Colorectal Surgery",
                  "description": "Hemorrhoids, colorectal cancer, fistulae.",
                  "notes": "### ğŸš½ Colorectal Surgery\n\nManages diseases of the colon, rectum, and anus.\n\n---\n\n### ğŸ’¥ Common Conditions\n- **Hemorrhoids**: Internal painless bleed; tx: rubber band or hemorrhoidectomy\n- **Fistula-in-ano**: Tract from rectum to skin; tx: fistulotomy\n- **Colorectal cancer**: Altered bowel, bleeding, weight loss; screen @ 50y (colonoscopy)\n\n---\n\n### ğŸ§  Key Takeaway\nColorectal symptoms = **never ignore bleeding or change in habits** â†’ rule out cancer."
                },
                {
                  "title": "Breast Surgery",
                  "description": "Breast cancer diagnosis and operative management.",
                  "notes": "### ğŸ—ï¸ Breast Surgery\n\nIncludes diagnosis, staging, and treatment of **benign and malignant breast diseases**.\n\n---\n\n### ğŸ”¬ Diagnosis\n- Triple assessment: **Clinical + Imaging (US/mammo) + Biopsy**\n\n### ğŸ§ª Cancer Types\n- DCIS, invasive ductal/lobular\n- ER/PR/HER2 status guides therapy\n\n### ğŸ› ï¸ Surgical Options\n- Lumpectomy (breast-conserving)\n- Mastectomy Â± reconstruction\n- SLNB or axillary clearance\n\n---\n\n### ğŸ§  Key Takeaway\n**Early detection + tailored surgery** = best outcomes in breast cancer."
                },
                {
                  "title": "Postoperative Complications",
                  "description": "Bleeding, infection, DVT, wound healing.",
                  "notes": "### âš ï¸ Postoperative Complications\n\nSurveillance is key after surgery â€” catch issues **early**.\n\n---\n\n### ğŸ“† Timing Clues\n- POD 1â€“2: **Atelectasis**, pneumonia\n- POD 3â€“5: **UTI**, wound infection\n- POD 5â€“7: **DVT/PE**, anastomotic leak\n\n### ğŸ©¸ Types\n- Bleeding: Internal or drain output\n- Infection: Fever, erythema, pus\n- DVT: Leg pain/swelling â†’ US + anticoagulation\n- Poor healing: Diabetes, steroids\n\n---\n\n### ğŸ§  Key Takeaway\nPost-op care = monitor **vitals, drains, wounds, mobility** â€” prevent **big problems early**."
                }
              ]
            },
            {
              "name": "Pediatrics (Advanced)",
              "topics": [
                {
                  "title": "Congenital Heart Disease",
                  "description": "Types, murmur recognition, cyanotic vs acyanotic.",
                  "notes": "### ğŸ’“ Congenital Heart Disease (CHD)\n\nMost common congenital defect â€” present with **murmur, cyanosis, failure to thrive**.\n\n---\n\n### ğŸ”µ Cyanotic (5 Ts)\n- Tetralogy of Fallot (boot-shaped heart)\n- Transposition of great vessels\n- Truncus arteriosus\n- Tricuspid atresia\n- TAPVR\n\n### ğŸ”´ Acyanotic\n- VSD (most common)\n- ASD, PDA, coarctation of aorta\n\n---\n\n### ğŸ§ª Dx & Tx\n- Echo = gold standard\n- Surgery/intervention depends on defect + severity\n\n---\n\n### ğŸ§  Key Takeaway\n**Early detection + timely repair** prevent irreversible pulmonary HTN and failure."
                },
                {
                  "title": "Neonatal Care",
                  "description": "APGAR, common neonatal complications, feeding.",
                  "notes": "### ğŸ‘¶ Neonatal Care Basics\n\nFirst 28 days = **critical for survival and growth**.\n\n---\n\n### ğŸ©º APGAR Score (1 & 5 min)\n- Appearance, Pulse, Grimace, Activity, Respiration (0â€“2 each)\n\n### ğŸš¼ Key Complications\n- Respiratory distress syndrome (preterms)\n- Neonatal jaundice (physiologic vs pathologic)\n- Hypoglycemia, hypothermia\n\n### ğŸ¼ Feeding\n- Breastfeeding preferred â€” start within 1 hour\n- Monitor weight, stool, urine\n\n---\n\n### ğŸ§  Key Takeaway\nGood neonatal care = **thermal, nutritional, infection control** + **early detection** of issues."
                },
                {
                  "title": "Pediatric Oncology",
                  "description": "Leukemia, lymphoma, solid tumors.",
                  "notes": "### ğŸ§¬ Pediatric Oncology\n\nChildhood cancers are often **hematologic or embryonal**.\n\n---\n\n### âš¡ Most Common Cancers\n- **ALL**: Bone pain, bruising, blasts in blood/marrow\n- **Lymphomas**:\n  - Hodgkin (Reed-Sternberg): Painless node + B symptoms\n  - Non-Hodgkin: Rapid, extranodal\n- **Neuroblastoma**: Abdominal mass, catecholamines\n- **Wilms tumor**: Kidney mass, hematuria\n\n---\n\n### ğŸ“Š Diagnosis & Tx\n- CBC, biopsy, imaging\n- Chemo-based, some need surgery/radiation\n\n---\n\n### ğŸ§  Key Takeaway\nPediatric cancers = **rapid onset**, often **curable with early multi-modality care**."
                }
              ]
            },
            
            {
              "name": "Public Health and Epidemiology",
              "topics": [
                {
                  "title": "Epidemiologic Measures",
                  "description": "Incidence, prevalence, risk, odds ratios.",
                  "notes": "### ğŸ“Š Epidemiologic Measures\n\nUsed to quantify disease **burden, association, and risk**.\n\n---\n\n### ğŸ§® Definitions\n- **Incidence**: New cases / population at risk over time\n- **Prevalence**: All existing cases / total population\n- **Risk**: Probability of developing disease\n- **Odds Ratio (OR)**: Odds in exposed / odds in unexposed (used in case-control)\n- **Relative Risk (RR)**: Risk in exposed / risk in unexposed (used in cohort)\n\n---\n\n### ğŸ§  Key Takeaway\nUse **incidence** for causality, **prevalence** for burden â€” OR â‰ˆ RR in rare diseases."
                },
                {
                  "title": "Screening and Prevention",
                  "description": "Sensitivity, specificity, population programs.",
                  "notes": "### ğŸ§ª Screening & Prevention\n\nEarly detection improves outcomes â€” but needs balance.\n\n---\n\n### ğŸ©º Test Characteristics\n- **Sensitivity**: True positives / all with disease\n- **Specificity**: True negatives / all without disease\n- **PPV/NPV** depend on prevalence\n\n### ğŸ¯ Levels of Prevention\n- **Primary**: Prevent disease (vaccines)\n- **Secondary**: Early detect (screening)\n- **Tertiary**: Limit impact (treatment, rehab)\n\n---\n\n### ğŸ§  Key Takeaway\nGreat screening = **high sensitivity**, easy, safe, and improves **morbidity/mortality**."
                },
                {
                  "title": "Study Designs",
                  "description": "Cohort, case-control, RCT, cross-sectional.",
                  "notes": "### ğŸ§¬ Study Designs Overview\n\nDetermine causation, association, or prevalence.\n\n---\n\n### ğŸ“Œ Types\n- **Cohort**: Exposure â†’ outcome (prospective/retrospective) â†’ RR\n- **Case-control**: Outcome â†’ exposure (retrospective) â†’ OR\n- **RCT**: Randomized, controlled = gold standard\n- **Cross-sectional**: Snapshot (prevalence study)\n\n---\n\n### ğŸ§  Key Takeaway\n**Design choice affects bias, cost, validity** â€” RCTs are best, but not always feasible."
                },
                {
                  "title": "Outbreak Investigation",
                  "description": "Steps in managing public health outbreaks.",
                  "notes": "### ğŸ” Outbreak Investigation\n\nA stepwise approach to identify cause and contain disease spread.\n\n---\n\n### ğŸš¨ Steps\n1. Confirm diagnosis & outbreak\n2. Define case & count cases\n3. Describe in time/place/person\n4. Develop & test hypotheses\n5. Implement control measures\n6. Communicate findings\n\n---\n\n### ğŸ§  Key Takeaway\nOutbreaks require **rapid, structured response** â†’ protect the public + find the source fast."
                }
              ]
            }
            ,
            {
              "name": "Radiology and Lab Medicine",
              "topics": [
                {
                  "title": "Chest CT and Abdominal Imaging",
                  "description": "Interpretation of CT findings in trauma, infection, cancer.",
                  "notes": "### ğŸ–¼ï¸ Chest CT & Abdominal Imaging\n\nCT provides **high-resolution, cross-sectional anatomy** â€” critical for trauma and pathology.\n\n---\n\n### ğŸ« Chest CT\n- **PE**: Filling defect in pulmonary artery (CT-PA)\n- **Infection**: Consolidation, ground-glass opacities (e.g. COVID)\n- **Cancer**: Mass, lymphadenopathy\n\n### ğŸ©» Abdominal CT\n- **Appendicitis**: Enlarged, non-compressible appendix\n- **Diverticulitis**: Inflamed outpouchings, pericolic fat stranding\n- **Cancer**: Irregular mass, lymph node enlargement\n\n---\n\n### ğŸ§  Key Takeaway\nCT = best for **solid organ injury, bleeding, staging** â€” always consider **radiation dose**."
                },
                {
                  "title": "Lab Interpretation Basics",
                  "description": "CBC, LFTs, RFTs, electrolytes.",
                  "notes": "### ğŸ§ª Lab Interpretation 101\n\nUsed daily for diagnosis, monitoring, and triage.\n\n---\n\n### ğŸ“‹ CBC\n- **Hb/Hct**: Anemia, polycythemia\n- **WBC**: Infection, leukemias\n- **Platelets**: Bleeding risk\n\n### ğŸ“Š LFTs\n- ALT/AST â†‘: Hepatic injury\n- ALP/GGT â†‘: Biliary obstruction\n- Albumin, INR: Synthetic function\n\n### ğŸ’§ RFTs & Electrolytes\n- Creatinine, BUN: Renal function\n- Na/K/Cl/HCOâ‚ƒâ»: Fluid balance\n\n---\n\n### ğŸ§  Key Takeaway\nTrend labs over time â€” **context + correlation** guide decisions, not single numbers."
                },
                {
                  "title": "Diagnostic Algorithms",
                  "description": "Integrating labs and imaging in clinical diagnosis.",
                  "notes": "### ğŸ§  Diagnostic Algorithms\n\nUse **stepwise thinking** to reduce error and delay.\n\n---\n\n### ğŸ©º Example: Chest Pain\n1. ECG + troponin\n2. If normal, D-dimer (if low-risk)\n3. If elevated â†’ CT-PA\n4. If negative â†’ GI or MSK cause\n\n### ğŸ§ª Example: Jaundice\n- ALT/AST â†‘ = hepatitis\n- ALP/GGT â†‘ = obstruction â†’ US\n- If both â†‘ = mixed â†’ CT/ERCP\n\n---\n\n### ğŸ§  Key Takeaway\nAlgorithms save time, reduce guesswork â€” always start with **broad + non-invasive**."
                }
              ]
            }
            ,
            {
              "name": "Family Medicine",
              "topics": [
                {
                  "title": "Chronic Disease Management",
                  "description": "Diabetes, HTN, asthma in primary care.",
                  "notes": "### ğŸ©º Chronic Disease Management\n\nCore role of family medicine = **continuity and coordination** of long-term conditions.\n\n---\n\n### ğŸ“Œ Diabetes\n- HbA1c target <7%\n- Metformin 1st-line â†’ add SGLT2i/GLP-1RA for CV/renal protection\n\n### ğŸ“Œ Hypertension\n- Target BP <140/90 (or <130/80 in high-risk)\n- ACEi/ARB, thiazide, CCB\n\n### ğŸ“Œ Asthma\n- Stepwise tx: SABA â†’ ICS â†’ LABA â†’ leukotriene modifiers\n- Action plan + trigger avoidance\n\n---\n\n### ğŸ§  Key Takeaway\nChronic care = patient partnership, **lifestyle support**, and regular monitoring."
                },
                {
                  "title": "Preventive Medicine",
                  "description": "Screening and lifestyle counseling.",
                  "notes": "### ğŸ›¡ï¸ Preventive Medicine\n\nShifts focus from **treatment to prevention**.\n\n---\n\n### ğŸ¯ Screenings\n- Pap smear: Every 3 yrs (21â€“65)\n- Mammogram: Every 2 yrs (50â€“74)\n- Colonoscopy: q10y from 50 (or FIT yearly)\n- Lipids: >40 y/o, or earlier if risk factors\n\n### ğŸ§˜ Lifestyle Interventions\n- Diet: DASH, low salt/sugar/fat\n- Exercise: 150 min/week\n- Smoking cessation support\n\n---\n\n### ğŸ§  Key Takeaway\nEarly detection + behavior change = **lower disease burden and cost**."
                },
                {
                  "title": "Patient-Centered Interviewing",
                  "description": "Building rapport, exploring concerns, shared decision making.",
                  "notes": "### ğŸ’¬ Patient-Centered Interviewing\n\nFoundation of **primary care trust and compliance**.\n\n---\n\n### ğŸ¤ Principles\n- Open-ended questions first\n- Explore patient ideas, fears, expectations\n- Empathy: Acknowledge emotion\n- Use **shared decision making**\n- Address psychosocial context\n\n### ğŸ“‹ Techniques\n- Ask â†’ Listen â†’ Summarize\n- â€œWhat matters most to you today?â€\n\n---\n\n### ğŸ§  Key Takeaway\nPatients remember **how you made them feel** â€” listening is therapeutic."
                }
              ]
            }
            
          ]
        },        
        {
          "year": 6,
          "subjects": [
            {
              "name": "Emergency & Critical Care",
              "topics": [
                {
                  "title": "Cardiac Arrest and ACLS",
                  "description": "Management of cardiac arrest and resuscitation algorithms.",
                  "notes": "### â¤ï¸ Cardiac Arrest & ACLS\n\nUse **ACLS algorithm** to guide rapid action in cardiac arrest.\n\n---\n\n### ğŸ§­ Key Steps\n1. Confirm unresponsiveness, call for help\n2. Start **CPR** immediately (100â€“120/min)\n3. Attach **defibrillator/monitor**\n4. Shockable (VF/pVT): Shock â†’ CPR â†’ drugs\n5. Non-shockable (asystole/PEA): CPR â†’ **epi q3â€“5 min**\n\n---\n\n### ğŸ’‰ Drugs\n- **Epinephrine**: All rhythms\n- **Amiodarone**: VF/pVT if refractory\n\n---\n\n### ğŸ§  Key Takeaway\nHigh-quality CPR + early defibrillation = **greatest survival impact**."
                },
                {
                  "title": "Airway Management",
                  "description": "Intubation techniques and ventilation basics.",
                  "notes": "### ğŸ« Airway Management\n\nEnsure a **patent airway** in emergencies or critical illness.\n\n---\n\n### ğŸ”‘ Techniques\n- **Bag-valve-mask (BVM)**: Temporary\n- **Oropharyngeal/Nasopharyngeal airway**: For unconscious\n- **Endotracheal Intubation**: Gold standard\n- **Rapid Sequence Intubation (RSI)**: Preoxygenate â†’ sedative â†’ paralytic\n\n---\n\n### âš™ï¸ Ventilation\n- Tidal volume: ~6â€“8 mL/kg\n- Monitor Oâ‚‚, COâ‚‚, airway pressure\n\n---\n\n### ğŸ§  Key Takeaway\nAlways assess **airway patency**, then plan definitive protection early."
                },
                {
                  "title": "Sepsis and Shock",
                  "description": "Recognition, diagnosis, and rapid treatment.",
                  "notes": "### ğŸ§¬ Sepsis and Shock\n\nSepsis = life-threatening **organ dysfunction** due to dysregulated infection.\n\n---\n\n### ğŸš© Criteria\n- Suspected infection + **SOFA score â†‘ â‰¥2**\n- **qSOFA**: AMS, RR â‰¥22, SBP â‰¤100\n\n### ğŸ§ª Labs\n- Lactate â†‘, cultures, CBC, creatinine, LFTs\n\n### ğŸ’‰ Treatment (Hour-1 Bundle)\n1. Fluids (30 mL/kg crystalloid)\n2. Cultures â†’ broad-spectrum **antibiotics**\n3. Vasopressors if MAP <65\n\n---\n\n### ğŸ§  Key Takeaway\nSepsis = **time-sensitive** â€” early fluids, antibiotics, and monitoring = survival."
                },
                {
                  "title": "Trauma Protocols",
                  "description": "Primary and secondary survey, massive transfusion protocol.",
                  "notes": "### ğŸ©¸ Trauma Protocols\n\nFollow **ATLS** framework in all major trauma.\n\n---\n\n### ğŸ”¤ Primary Survey: ABCDE\n- A: Airway + spine\n- B: Breathing\n- C: Circulation\n- D: Disability (neuro)\n- E: Exposure + temperature\n\n### ğŸ” Secondary Survey\n- Head-to-toe + history (AMPLE)\n\n### ğŸ’‰ Massive Transfusion Protocol\n- 1:1:1 ratio of PRBC:Plasma:Platelets\n- Monitor CaÂ²âº, temp, coagulation\n\n---\n\n### ğŸ§  Key Takeaway\nTrauma care = **structured, repeatable** â†’ saves lives under pressure."
                }
              ]
            },
            {
              "name": "Clinical Integration & Decision-Making",
              "topics": [
                {
                  "title": "Approach to Undifferentiated Complaints",
                  "description": "Chest pain, SOB, abdominal pain, fever.",
                  "notes": "### ğŸ” Approach to Undifferentiated Complaints\n\nStart with **life-threatening causes**, then narrow down.\n\n---\n\n### ğŸ§  4 Key Presentations\n- **Chest Pain**: Rule out MI, PE, dissection â†’ then GERD, MSK\n- **SOB**: PE, CHF, asthma/COPD, pneumonia\n- **Abdominal Pain**: Surgical vs medical â†’ location = clue (RUQ = cholecystitis, RLQ = appy)\n- **Fever**: Source hunt â€” chest, urine, wound, line\n\n---\n\n### ğŸ§  Key Takeaway\nUse **pattern + red flags + system review** to identify critical vs benign."
                },
                {
                  "title": "Diagnostic Reasoning",
                  "description": "Clinical pattern recognition and Bayesian thinking.",
                  "notes": "### ğŸ§  Diagnostic Reasoning\n\nInvolves **matching symptoms to disease patterns** and updating based on new data.\n\n---\n\n### ğŸ§  Dual Process Model\n- **System 1**: Fast, intuitive â€” pattern recognition\n- **System 2**: Slow, analytical â€” hypothetico-deductive\n\n### ğŸ¯ Bayesian Thinking\n- **Pre-test probability** Ã— test characteristics â†’ **post-test probability**\n- Example: D-dimer in low-risk patient = rule out\n\n---\n\n### ğŸ§  Key Takeaway\nExpert diagnosis = **recalibrating with new info** â€” not guessing!"
                },
                {
                  "title": "Management Planning",
                  "description": "Building differential â†’ confirm â†’ treat â†’ follow-up.",
                  "notes": "### ğŸ—‚ï¸ Management Planning\n\nClinical decisions = structured, staged actions.\n\n---\n\n### ğŸªœ Steps\n1. **Create differential**: Based on H&P\n2. **Prioritize**: Life-threatening first\n3. **Confirm**: Labs, imaging, biopsies\n4. **Treat**: Etiologic + symptomatic\n5. **Follow-up**: Monitor response, adjust\n\n---\n\n### ğŸ“Œ Tools\n- SOAP notes\n- Clinical pathways/guidelines\n- Shared decision-making\n\n---\n\n### ğŸ§  Key Takeaway\nGreat clinicians don't just diagnose â€” they **plan, adjust, and reassess** continuously."
                }
              ]
            }
            ,
            {
              "name": "Medical Ethics and Law",
              "topics": [
                {
                  "title": "Medical Consent & Capacity",
                  "description": "Informed consent, competence, surrogates.",
                  "notes": "### ğŸ“ Consent & Capacity\n\nConsent is valid if itâ€™s **informed, voluntary, and competent**.\n\n---\n\n### âœ… Consent Criteria\n- **Capacity**: Understand, retain, weigh, communicate\n- **Informed**: Risks, benefits, alternatives\n- **Voluntary**: No coercion\n\n### ğŸ” Surrogates\n- Used when patient lacks capacity\n- Follow advance directives or legal hierarchy\n\n---\n\n### ğŸ§  Key Takeaway\nNo procedure without valid consent â€” **respect autonomy** and **legal standards**."
                },
                {
                  "title": "Medical Negligence and Legal Risk",
                  "description": "Duty of care, malpractice, documentation standards.",
                  "notes": "### âš–ï¸ Medical Negligence\n\nOccurs when thereâ€™s a breach in **duty of care** causing harm.\n\n---\n\n### ğŸ” 4 Dâ€™s of Negligence\n1. **Duty**: Established doctorâ€“patient relationship\n2. **Dereliction**: Breach of standard\n3. **Direct causation**: Harm from breach\n4. **Damages**: Actual injury or loss\n\n### ğŸ“‹ Risk Management\n- Document clearly\n- Communicate openly\n- Follow guidelines\n\n---\n\n### ğŸ§  Key Takeaway\nGood records + communication = **legal protection + safer care**."
                },
                {
                  "title": "Resource Allocation",
                  "description": "Triage, rationing, end-of-life decisions.",
                  "notes": "### ğŸ§® Resource Allocation\n\nBalancing individual care with **population justice** in limited-resource settings.\n\n---\n\n### ğŸ”‘ Principles\n- **Justice**: Fair distribution\n- **Utility**: Maximize benefit\n- **Autonomy**: Respect choice\n- **Equity**: Prioritize vulnerable\n\n### ğŸ¥ Scenarios\n- ICU beds during crisis\n- Organ transplant lists\n- Triage in mass casualty\n\n---\n\n### ğŸ§  Key Takeaway\nEthical allocation = **transparent, consistent, and evidence-based** decisions."
                }
              ]
            }
            ,
            {
              "name": "Internship Prep Skills",
              "topics": [
                {
                  "title": "Discharge Planning",
                  "description": "Patient safety, medication reconciliation.",
                  "notes": "### ğŸ“¦ Discharge Planning\n\nA good discharge prevents **readmission** and ensures safe continuity of care.\n\n---\n\n### âœ… Key Components\n- **Diagnosis summary**\n- **Medication reconciliation**\n- **Follow-up plans**: Appointments, labs, referrals\n- **Patient instructions**: Clear, in lay terms\n\n### ğŸ§ª Common Pitfalls\n- Missing med changes\n- Poor documentation\n- Unclear instructions\n\n---\n\n### ğŸ§  Key Takeaway\nDischarge = handoff to real life â†’ **clarity + coordination** = safe transition."
                },
                {
                  "title": "Common Ward Emergencies",
                  "description": "Hypoglycemia, acute chest pain, hypotension.",
                  "notes": "### ğŸš¨ Ward Emergencies\n\nEarly recognition + calm action = saves lives.\n\n---\n\n### âš ï¸ Key Emergencies\n- **Hypoglycemia**: Sweating, confusion â†’ Check glucose, give dextrose\n- **Chest Pain**: ECG + vitals â†’ MI, PE, dissection?\n- **Hypotension**: BP <90 â†’ assess volume, sepsis, bleed\n\n### ğŸ©º First Steps\n- ABCs â†’ Monitor â†’ Vitals â†’ Notify senior\n- Always **reassess** after intervention\n\n---\n\n### ğŸ§  Key Takeaway\nInterns arenâ€™t alone â€” but your **speed + organization** makes the difference."
                },
                {
                  "title": "Writing Admission and Progress Notes",
                  "description": "SOAP format, clarity, and completeness.",
                  "notes": "### ğŸ“ Notes: Admission & Daily Progress\n\nClear notes = good care + legal protection.\n\n---\n\n### ğŸ“‹ SOAP Format\n- **S**ubjective: Patient-reported sx\n- **O**bjective: Vitals, labs, exams\n- **A**ssessment: Diagnosis + differentials\n- **P**lan: Tests, treatments, consults\n\n### ğŸ–Šï¸ Tips\n- Be concise but complete\n- Avoid vague phrases (e.g. â€œdoing fineâ€)\n- Use bullet points for clarity\n\n---\n\n### ğŸ§  Key Takeaway\nGood notes = good communication â†’ document what you saw, thought, and did."
                }
              ]
            }
            ,
            {
              "name": "Professionalism and Communication",
              "topics": [
                {
                  "title": "Difficult Conversations",
                  "description": "Conflict resolution, cultural competence.",
                  "notes": "### ğŸ’¬ Difficult Conversations\n\nTough talks = **compassion + clarity**.\n\n---\n\n### ğŸ› ï¸ Strategies\n- Use SPIKES or similar framework\n- Acknowledge emotions\n- Listen actively before responding\n\n### ğŸŒ Cultural Competence\n- Ask open-ended: â€œWhat does this mean to you?â€\n- Avoid assumptions; adapt care to values\n\n---\n\n### ğŸ§  Key Takeaway\nConflict or emotion â‰  avoid â†’ use **empathy + skill to build trust**."
                },
                {
                  "title": "Team Communication",
                  "description": "SBAR, handover protocols, closed-loop communication.",
                  "notes": "### ğŸ§‘â€ğŸ¤â€ğŸ§‘ Team Communication\n\nHealthcare = **team sport**. Clear, structured talk saves lives.\n\n---\n\n### ğŸ§¾ Tools\n- **SBAR**: Situation, Background, Assessment, Recommendation\n- **Handover**: Include active issues, plans, contact\n- **Closed-loop**: Confirm every message (esp. critical tasks)\n\n---\n\n### ğŸ§  Key Takeaway\n**Safety = communication**. Make sure youâ€™re heard and understood."
                },
                {
                  "title": "Leadership and Advocacy",
                  "description": "Acting as patient advocate and healthcare leader.",
                  "notes": "### ğŸ§­ Leadership & Advocacy\n\nGreat doctors **influence, guide, and advocate**.\n\n---\n\n### ğŸ§  Clinical Leadership\n- Set example: punctual, ethical, proactive\n- Lead rounds, respond to crises, stay humble\n\n### ğŸ¤ Advocacy\n- Patient-centered care\n- Speak up for underserved\n- Participate in health policy when able\n\n---\n\n### ğŸ§  Key Takeaway\nDoctors lead by example â€” in **decisions, demeanor, and dedication**."
                }
              ]
            }
            ,
            {
              "name": "Global and Preventive Health",
              "topics": [
                {
                  "title": "Global Burden of Disease",
                  "description": "DALYs, major contributors, public health responses.",
                  "notes": "### ğŸŒ Global Burden of Disease (GBD)\n\nGBD = **morbidity + mortality worldwide**.\n\n---\n\n### ğŸ“Š Metrics\n- **DALYs** = YLL + YLD (disability-adjusted life years)\n- Leading causes: CV disease, lower resp infections, neonatal disorders\n\n### ğŸ¥ Priorities\n- Maternal-child health\n- Vaccination\n- Non-communicable diseases (NCDs)\n\n---\n\n### ğŸ§  Key Takeaway\nUnderstanding GBD helps prioritize **cost-effective, life-saving health interventions**."
                },
                {
                  "title": "Disaster Medicine",
                  "description": "Triage, logistics, and medical care in crises.",
                  "notes": "### âš ï¸ Disaster Medicine\n\nPreparedness for mass casualty = **maximize survival with limited resources**.\n\n---\n\n### ğŸ§­ Triage Categories\n- Red: Immediate\n- Yellow: Delayed\n- Green: Minor\n- Black: Expectant/deceased\n\n### ğŸ”§ Key Skills\n- Field organization\n- Incident command\n- Resource allocation\n\n---\n\n### ğŸ§  Key Takeaway\nCrisis care = **simple, structured, scalable** to save as many as possible."
                },
                {
                  "title": "Occupational and Environmental Health",
                  "description": "Exposure risk, workplace safety, pollution effects.",
                  "notes": "### ğŸ§ª Occupational & Environmental Health\n\nFocus on **preventing harm from work and surroundings**.\n\n---\n\n### ğŸ­ Hazards\n- Noise, dust, toxins (e.g. asbestos, lead)\n- Zoonoses, ergonomic injuries\n- Heat stroke, chemical spills\n\n### ğŸŒ± Environmental\n- Air & water pollution â†’ COPD, CA\n- Climate change = rising heat injury, vector diseases\n\n---\n\n### ğŸ§  Key Takeaway\nPrevention in workplace + environment = huge return in **public health and productivity**."
                }
              ]
            }
            
          ]
        }
    ]
  }
  